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“If we knew what it was we were doing it would not be called research, would it?” 
Albert Einstein 

  
ABSTRACT 
Correct medical treatment necessitates a correct diagnosis. Cardiac imaging aims to establish 
an accurate diagnosis without performing unnecessary invasive procedures. Cardiovascular 
magnetic resonance (CMR) has emerged as a valuable diagnostic tool in clinical cardiology 
because of its inherently good soft-tissue contrast, dynamic visualizations and the possibility 
to perform quantitative tissue characterization. However, diagnostic precision may be 
affected in quantitative imaging by several factors such as the presence of sex differences, or 
measurements errors. Therefore, the aim of this thesis was to identify parameters and sex 
differences that affect precision and accuracy, and to evaluate post-processing methods to 
increase diagnostic precision.  
We found that intramyocardial blood affects native myocardial 𝑇"	values in patients without 
focal abnormalities, and that native myocardial 𝑇" values differ between the sexes. We 
developed a blood correction model that maintained an increase in diagnostic precision by 
13% when applied to an independent patient cohort, which furthermore also eliminated sex 
differences in healthy volunteers in Study I. In Study II, we evaluated a post-processing 
method called stationary tissue background correction for increasing diagnostic precision in 
clinical blood flow measurements. We found that the number of patients with a pulmonary-
to-systemic blood flow ratio (Qp/Qs) outside of the normal range decreased following 
stationary tissue background correction. In Study III, we investigated the presence of sex 
differences in a newly developed myocardial perfusion imaging sequence in healthy 
volunteers. We found that women have higher myocardial blood volume, myocardial 
perfusion and myocardial extracellular volume compared to men both at rest and during 
adenosine stress, which provide mechanistic insight into myocardial physiology. In Study IV, 
we investigated the clinical accuracy and precision of synthetic scar images (SynLGE) from 
post-contrast 𝑇" maps compared to conventional scar images (LGE) for diagnosing focal 
myocardial fibrosis of any etiology. Compared to LGE, SynLGE yielded a sensitivity of 77%, 
a specificity of 98%, a positive predictive value of 97% and a negative predictive value of 
86%. 
In conclusion, there are sex differences in several aspects of clinical quantitative CMR 
imaging that may affect diagnostic precision. Post-processing is a powerful tool to improve 
diagnostic precision both by increasing precision in native myocardial 𝑇" values via blood 
correction, and in Qp/Qs via stationary tissue background correction. SynLGE can provide 
complementary confidence in the assessment of focal myocardial fibrosis in complement to 
conventional LGE, and thereby increase diagnostic accuracy and precision.  
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1 INTRODUCTION 
Correct medical treatment necessitates a correct diagnosis. Cardiac imaging aims to establish 
an accurate diagnosis without performing unnecessary invasive procedures. Several non-
invasive cardiac imaging modalities are in clinical use today. Echocardiography, cardiac 
computed tomography (CT), cardiac nuclear medicine imaging (NM), and CMR all convey 
valuable diagnostic information about the heart’s anatomy and function. However, each 
technique has limitations ranging from radiation burden to the inability to perform 
myocardial tissue characterization.  
Echocardiography generates images from ultrasound waves that are reflected in the heart and 
detected by a transducer. Echocardiography is particularly suitable for assessing the motion 
of the left ventricular (LV) wall, as well as identifying functional abnormalities [1], valve 
abnormalities and pericardial effusion. While echocardiography is readily available, this 
imaging method has a limited ability to directly characterize myocardial tissue properties [2]. 
Cardiac CT has evolved into an important imaging method to evaluate coronary calcification 
[2], cardiac and coronary anatomy, and function [3]. The established method to quantify 
coronary calcification, the coronary artery calcium (CAC) score, can predict the likelihood of 
coronary events [4]. Coronary CT angiography (CCTA) is another important cardiac CT 
technique. CCTA has a very high specificity and negative predictive value (NPV). Therefore, 
CCTA is an appropriate tool to use for intermediate risk patients who present with chest pain 
in the emergency room, to rule out acute coronary syndrome (ACS) [5, 6]. NM is an 
important tool for myocardial perfusion imaging (MPI) and viability assessment with the use 
of radiotracers in positron emission tomography (PET) and single-photon emission computed 
tomography (SPECT) [7]. PET enables non-invasive absolute quantification of myocardial 
perfusion, which is also sometimes referred to myocardial blood flow (MBF). By calculating 
the ratio of the peak perfusion at maximal pharmacological vasodilation to perfusion at rest, 
the coronary flow reserve (CFR) can be calculated. CFR is an important measure for 
evaluating the functional relevance of a coronary stenosis [8, 9]. Prior to the year 2000, PET 
was regarded as the reference standard for myocardial viability imaging. However, since the 
introduction of the CMR technique known as late gadolinium enhancement (LGE), which 
allows for detailed tissue characterization, LGE CMR has become the modality of choice for 
viability imaging [10].  
CMR has emerged as a robust imaging technique for a comprehensive set of states including 
cardiac anatomical morphology [11], tissue characterization [12-15], LV and right ventricular 
function [2, 16], myocardial wall thickness and viability [10, 17], myocardial perfusion [18-
20], and blood flow [21]. Consequently, CMR has become an important diagnostic and 
scientific tool in clinical cardiology. 
Why is it important to know the correct diagnosis? Cardiovascular disease (CVD) is the 
leading cause of death [22] globally. Many lives can be saved, and quality of life improved if 
we correctly can identify patients that are in need of treatment. This thesis aims to evaluate 
the diagnostic precision of several clinical CMR methods, identify areas of improvement, and 
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even in some cases propose new improved methods to increase diagnostic accuracy and 
precision of CMR.  
1.1 IMPORTANT CONCEPTS 
Before elaborating on the background of clinical CMR and its role in clinical diagnostics, 
there are a few important concepts that need to be defined.  
1.1.1 Sex and gender 
Sex and gender are two different concepts that often interact in disease. However, they have 
separate, distinct definitions according to the Canadian Institutes of Health Research [23]. 
Sex include the biological characteristics of both humans and animals, and biological 
attributes include both physical and physiological features. These features comprise of 
chromosomes, and gene expression, but also hormone levels and function, as well as 
reproductive anatomy. Gender, on the other hand, refers to the social construction of roles, 
expressions, behaviors and personalities of individual boys, men, girls, women and gender 
diverse, non-binary individuals. Gender is closely linked to how people perceive each other 
and themselves, and influences how people act and interact. Gender is often described as 
binary (woman and man). However, gender is experienced and expressed with a great variety 
in different individuals and groups. It is important to separate these concepts as the 
physiological factors and the social constructions affect CVD differently.  
1.1.2 Accuracy and precision  
There are two concepts that can be used to described how we know what we think we know 
when discussing any diagnostic measurement. These two concepts are accuracy and 
precision (Figure 1.1). Accuracy and precision help to describe the diagnostic measurement 
in terms of how variable the test results are, and how close to the true value the test results 
are [24]. Precision describes the random errors that occur when measuring a quantity, it is a 
measure of statistical variability. Accuracy describe the systematic error that occurs when 
measuring a quantity, it is a measure of statistical bias; the difference between the measured 
result and the true value of the quantity. 
  3 
 
Figure 1.1 Accuracy and precision. The figure illustrates the two concepts accuracy 
(columns), and precision (rows), with the bulls-eye representing the true values. The two 
concepts are completely independent of each other. A diagnostic test can be accurate and 
precise, as shown in the top left corner where all measurements are within the yellow circle. 
However, a diagnostic test can be inaccurate, not close to the true value, but yet be precise, 
meaning that the measurement variability is low. This is illustrated in the top right corner, 
where all measurements are outside the yellow circle, but the measurements are very close to 
each other. A diagnostic test can also be accurate, but imprecise, meaning that the 
measurement variability is high, which is illustrated by the bottom left corner. The 
measurements are evenly distributed around the yellow circle, close to the true value, 
however the measurements are far apart, representing the high measurement variability. The 
bottom right corner shows a diagnostic test that is both inaccurate and imprecise, and the 
measurements are not close to the yellow circle, and spread apart from each other.  
Reproduced from[25].  
Given a set of diagnostic measurements, the set can be called precise if the measurements are 
all close to the average value of the quantity being measured, while the set is accurate if the 
measurement are close to the true value of the quantity being measured. Accuracy and 
precision are independent of each other, so a set of diagnostic measurements can be either 
accurate or precise, or both, or neither [24]. A diagnostic measurement should preferably by 
both accurate and precise, however there are many measurements in clinical use that are only 
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accurate or precise, and this will be further exemplified and discussed with 𝑇" mapping in 
Section 2.3. 
1.1.3 Sensitivity, specificity, predictive values and Bayes theorem 
Other approaches to evaluate the performance of a diagnostic test include the terms 
sensitivity and specificity, as illustrated in Table 1.1. Sensitivity is the percent of true sick 
people where the test is positive for that disease. Sensitivity answers the question: in case a 
disease is present, what is the probability of a positive test? Specificity is the percent of 
healthy people where the test is negative for that disease. Specificity answers the question: in 
case a disease is absent, what is the probability of a negative test? [26]. For screening, it is 
essential to have a diagnostic test with high sensitivity, so that the diagnostic test identifies 
individuals that are truly sick. A test with high specificity can be used to rule out a certain 
disease, or to be certain that it is time to start a specific treatment.  
Predictive values describe the performance of the diagnostic test by indicating the accuracy of 
the test. The positive predictive value (PPV) reflects the proportion of positive test results that 
are truly positive, whereas NPV reflects the proportion of negative test results that indeed are 
negative.  
Table 1.1 Representation of sensitivity and specificity.  
 Sick (disease present) Healthy (disease absent) 
Positive test A B 
Negative test C D 
Sensitivity = A/(A+C), how many of patients (in %) that are sick, are positively identified 
with the test. Specificity = B/(B+D), how many patients (in %) that are truly healthy, have a 
negative test. PPV = A/(A+B), how many of the positive test results are truly positive (%). 
NPV = C/(C+D), how many negative test results are indeed negative (%).    
Bayes theorem  
Bayes theorem is used to decide the probability of an event, given knowledge of conditions 
that are related to the event. It enables an a priori estimation of the chances of a certain 
diagnosis to be merged with the eventual test results. This allows for an a posteriori 
assessment of the diagnosis, and in its essence reflecting clinical decision making [26]. 
Therefore, Bayes theorem is easily applicable to medical diagnostics. The probability of a test 
being positive for a certain disease is related to the probability of the disease prior to 
undergoing the diagnostic test (pre-test probability, PTP). If the PTP is low, like in young 
individuals for ischemic heart disease, testing for ischemic heart disease will therefore not 
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add diagnostic information. Instead, there is a risk for false positive results, which brings 
added risk for the patient, i.e. in the form of unnecessary procedures or treatments.  
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2 CARDIOVASCULAR MAGNETIC RESONANCE 
CMR can be performed repeatedly without any known hazardous side effects as the subject is 
not exposed to ionizing radiation, as in the case with cardiac CT and NM. Side effects can 
however be caused by the intravenous injection of gadolinium-based CMR contrast agents. 
Severe allergic reactions are exceedingly rare. The contrast agents may cause nephrogenic 
systemic fibrosis (NSF), however only in patients with severe renal disease [27]. An 
incidence of NSF after gadolinium-enhanced CMR was estimated to be 0.0002%-0.039% in 
2008 [28]. Recent studies suggest that there is a risk for brain deposition of gadolinium after 
repeated infusions [29, 30]. There is currently no evidence linking gadolinium deposition in 
the brain to neurological dysfunction, however the United States National Institutes of Health 
(NIH) warrants an institutional review of gadolinium administration policies [31]. Another 
disadvantage of CMR is the relatively long scan time, and the scan may be stressful for the 
patient, in particular those with claustrophobia. CMR is a relatively expensive imaging 
modality compared to echocardiography, with a typical cost in Sweden of approximately 
10,000 SEK and 3,000 SEK, respectively. However, CMR has become the clinical and 
scientific method of choice at many centers for characterizing ischemic and non-ischemic 
heart diseases [12].  
2.1 PHYSICS GOVERNING CARDIOVASCULAR MAGNETIC RESONANCE 
There are elaborate and complex procedures to generate the actual CMR images that the 
clinicians use to diagnose patients. This section will briefly describe the basics of Magnetic 
Resonance Imaging (MRI), in order to provide a basis for the discussion of the different 
CMR methods used in this thesis. MRI is based on the principle of nuclear magnetic 
resonance, and can be used to image the intrinsic magnetic properties of tissues. Three main 
parts constitutes an MRI scanner: the static magnetic field, the radio frequency (RF) coils and 
gradient coils. The static magnetic field, also called 𝐵&, is generated by a superconductive 
electromagnet, which is cooled with liquid helium to 4 Kelvin. Typically, the 𝐵& field of MRI 
scanners that are used clinically have a magnetic field strength of 1.5 Tesla (T) or 3 T. 
However, in laboratory settings up to 21 T have been used for imaging animals. Gradient and 
RF coils will be discussed further in the following sections.  
2.1.1 Spins – basis for signal generation 
MRI can produce detailed images of complex anatomical structures by imaging the intrinsic 
properties of tissues. How is this possible? 
Spin is a quantum property of elementary particles. The protons and neutrons in the atomic 
nucleus possess spin. In nuclei with an even number of protons and/or neutrons, the spins 
cancel out, but if the number is odd the nucleus possesses a net spin [32], which is the basis 
for the signal produced in MRI. Any species of nuclei with a net spin can be used, but the 
hydrogen atom is most commonly used for clinical imaging, due to its abundance in the 
human body as we are mostly made of water. The hydrogen nucleus consists of a single 
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proton, which, when placed in an external magnetic field, induces a local magnetic field as it 
spins around its own axis, making it behave similarly to a small bar magnet. The spins (spin 
vectors) of the hydrogen atoms in a sample (i.e. any given tissue) are randomly oriented until 
they are subjected to an external magnetic field, which causes the spins (vectors) to align 
along the direction of that magnetic field [33]. Spin, being a quantum mechanical concept, 
can only exist in quantized states. This is often described as protons aligning in a spin-up or a 
spin-down state, where the distribution between the states generates a net magnetization 
vector. This happens inside the body when a patient enters the scanner, the spins align with 𝐵& and the resulting net magnetization vector of the tissue (also called magnetization) can be 
used to generate an image signal. 
2.1.2 Generating the signal  
By applying a second, time-varying, magnetic field (𝐵") for a brief period of time, the net 
magnetization vector will turn at an angle from 𝐵&. The application of 𝐵" causes the spins to 
precess around 𝐵", the new magnetic field. If 𝐵" is applied along the y-axis, this will cause 
the magnetization to flip towards the x-axis. 𝐵"has to be transmitted at a precession frequency 
specific to the hydrogen nucleus, which depends on the local field strength. This is because 
the rate of precession is governed by the magnetic field that causes the precession, according 
to Equation 1.1 𝜔 = 𝛾 ∗ 𝐵& 
where the proportionality constant, 𝛾, is the gyromagnetic ratio and 𝜔 is called the Larmor 
frequency [34]. As the Larmor frequency at the field strengths used for clinical MRI scanning 
falls within the RF spectrum, the second magnetic field (𝐵") applied to move the net 
magnetization away from 𝐵&, is called an RF pulse and is applied by RF coils.  
Before going into magnetization relaxation and the use of gradient coils, we need some 
common ground or reference to further discuss the spatial movements of the magnetization. 
The direction of 𝐵&, denoted z, is positioned along the tube of the MR scanner. Since 
precession about 𝐵& is always present, it is common to define the coordinate system such that 
the xy-plane rotates about the z axis (Figure 2.1). Another important concept is phase. The 
magnetization vector has two basics properties, magnitude and direction. When a signal is 
measured, is it measured in the xy-plane, and the angle of magnetization in this plane will 
affect the signal and is known as phase. The ensemble of spins can be described as being in 
phase, rendering a higher signal amplitude, or out of phase, rendering a lower signal 
amplitude.  
  9 
 
Figure 2.1. Schematic visualization of the spatial movements of the magnetization. This 
diagram shows a rotating frame of reference. This means that the xy-plane is rotating about 
the z-axis with the same angular frequency as the magnetization vector, i.e. the Larmor 
frequency. A rotating frame of reference allows for a simplified visualization of the spatial 
movements of the magnetization. In this case, a radio frequency pulse has been applied to 
move the magnetization away from 𝐵& at an angle 𝜃.  
2.1.2.1 The intrinsic properties of tissues – 𝑇" and 𝑇, 
The net magnetization vector, induced by 𝐵& along the z-axis, will flip by a given angle 
towards the x-axis, when an RF pulse is applied along the y-axis. The given angle will be 
determined by the RF pulse, depending on the magnitude and duration of that RF pulse. The 
net magnetization vector has two different magnetization components – the transverse 
component (within the xy-plane) and the longitudinal component (along the z-axis). By 
applying an RF pulse of 90°, the entire longitudinal magnetization is now in the transverse 
plane. If the RF pulse purpose is to convert equilibrium magnetization into transversal 
magnetization, it is commonly known as an excitation pulse. The resultant transverse 
magnetization can now be measured by receiver coils. Immediately following the RF pulse, 
the spins precess in coherence, which induces a current in the receiver coils. But what 
happens over time following the RF pulse excitation? When the RF pulse is turned off, the 
net magnetization vector begins to return to the equilibrium position aligned in the 𝐵& 
direction, which is along the z-axis, where the spins experience the lowest energy state. Two 
things happen simultaneously, the magnetization in the xy-plane starts to decay (the 
transverse component), and the magnetization along the z-axis starts to recover (the 
longitudinal component). The magnetization decay is caused by so called spin-spin 
interactions, where the spins interact with each other, and also by small inhomogeneities in 
the magnetic field [33]. Both of these factors affect the rate and phase of precession, and 
thereby decreasing coherence of the spins, which leads to a decrease in the signal. Spin-spin 
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interactions reflect the composition of the tissue, whereas the magnetic field inhomogeneities 
can both reflect the environment of the tissue, such as presence of iron, but also the hardware 
of the scanner. The magnetization decay due to spin-spin interactions is called T2 relaxation, 
whereas the combined decay (spin-spin interaction and field inhomogeneities) is called T2* 
relaxation. T2* and T2 relaxation is described by Equation 1.2, and Equation 1.3. 
𝑀. = 	𝑀& ∗ 𝑒 0123∗ 1𝑇, ∗ = 	 1𝑇, + 	𝛾Δ𝐵& 
where 𝑀. is the magnetization along the y-axis, 𝑀&is the initial magnetization, t is the time 
after the RF pulse, and 𝛾Δ𝐵& is the difference in precession rate due to magnetic field 
inhomogeneities. T2 relaxation can visually be displayed (Figure 2.2) 
 
Figure 2.2 Visual representation of T2 relaxation. The vertical axis shows % of 
magnetization measured in the xy-plane and the horizontal axis shows time in ms. When the 
magnetization is brought down to the xy-plane by a 90° radio frequency pulse, the 
magnetization decays exponentially due to spin-spin interactions as displayed by the curve. 
T2 is defined as the time when the decay has reached 37% of the initial magnetization, which 
in this case is at 50 ms. In this case, we assume T2*=T2. 
Simultaneously as the transverse magnetization decays, longitudinal magnetization recovers. 
After a 90° RF pulse flips the magnetization to the xy-plane, the spins tend to return to their 
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thermal equilibrium around 𝐵&. This leads to the recovery, or regrowth, of the longitudinal 
magnetization (𝑀6) along the z-axis [33]. This process is known as 𝑇" relaxation, or 𝑇" 
recovery, and depends on the strength of 𝐵&, the tissue characteristics, and the surroundings. 𝑇" relaxation is an exponential process with a time constant, which is described by Equation 
1.3. 
𝑀6 = 	𝑀& ∗ (1 − 𝑒0 9:;)	, 
where t is the time after the RF pulse, 𝑇" is the time constant that expresses the time course of 
longitudinal relaxation until the magnetization vector reaches the initial equilibrium state, 𝑀& 
is the original magnetization (in equilibrium before any RF pulse is applied) and 𝑀6 is the 
magnitude of the magnetization along the z-axis. 𝑇" relaxation can also be visually displayed 
(Figure 2.3) 
 
Figure 2.3 Visual representation of 𝑇" relaxation. The vertical axis shows longitudinal 
magnetization in % of initial magnetization and the horizontal axis shows time in ms. After 
the magnetization is brought down to the xy-plane by a 90° radio frequency pulse, the 
magnetization, in the z-direction will exponentially recover until its initial magnitude is 
reached, as displayed by the curve. 𝑇" is defined as the time when roughly 63% (1-1/e) of the 
initial magnetization is recovered, which in this case is at 1000 ms. 
The magnitude of the longitudinal magnetization affects the signal intensity (SI) in the 
images. Fat, for example, has a shorter 𝑇" (the spins recover faster) than muscle, thus fat 
appears with a brighter signal in 𝑇"-weighted images. Furthermore, if gadolinium-based 
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contrast agent is present this will facilitate the dispersion on the spin energy [35], thereby 
accelerating the regrowth of the longitudinal magnetization, and thus increasing the image 
signal intensity. 
While RF pulses are most commonly used for excitation, there are many more uses in MRI. 
Most prominent in this work is the inversion pulse, which flips the magnetization along the 
transverse axis. The simplest design of an inversion pulse is similar to an excitation pulse, but 
with a 180° flip angle, but more advanced pulses such as adiabatic pulses are common.  𝑇"	and 𝑇, relaxation is inherent to every tissue, thereby providing distinctive information 
about a given tissue due to its composition. This is why MRI can provide detailed images of 
complex anatomical structures, since the inherent differences in magnetic properties cause 
image contrast depending on the timing of the RF-pulses.  
2.1.3 Location of signal origin 
So now we know how an image signal is generated, but how do we know the spatial location 
from which the received signal originated? In order to form a comprehensive image, the 
location of any part that is going to be visualized needs to be recorded. Now the third part of 
the MRI scanner, the gradient coils, work their magic. So called spatial encoding is 
performed by applying magnetic field gradients, using the gradient coils, in order to localize 
the spatial origin of the signal. As there are three spatial dimensions to consider, there are 
three encoding strategies that are usually employed; slice selection, frequency encoding and 
phase encoding.  
2.1.3.1 Slice selection 
Slice selection is performed by applying a magnetic gradient during the application of the RF 
pulse, which induces a slight difference in the magnetic field over the subject intended for 
imaging. The Larmor frequency is directly proportional to the field strength, and a gradient in 
the field strength will cause the spins to precess at different rates along the gradient. Only the 
spins with the precession rate of the RF pulse can be excited, which allows for signal 
recording from the slice selectively without interference from other slices [36].  
2.1.3.2 Phase encoding 
Once again, gradients are used to affect the phase of the spins, however the phase encoding 
gradient affect the entire spectrum of the frequency encoding direction. This means that in 
order to separate the signals’ spatial origin, the acquisition needs to be repeated as many 
times as the wanted number of picture elements in the phase encoding direction. As a 
consequence, the time needed to acquire an image is dependent on the resolution the phase 
encoding direction, but not the frequency encoding direction.  
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2.1.3.3 Frequency encoding 
By using the same technique that was used for slice selection, frequency encoding can be 
accomplished by applying a gradient that changes the frequency of the precession for 
different space points in one dimension [37]. However, instead of being applied during the 
RF pulse and interfering with the slice selection gradient, the frequency encoding gradient is 
applied during what is known as readout. The acquired signal will originate from spins 
precessing at distinctive rates due to their position along the frequency encoding direction. 
The Fourier transform, which translates frequencies into locations, can therefore be used to 
identify the positions of the original signals [36].  
2.1.4 Pulse sequences 
Now we know the basic principles for signal generation, and how a signal is translated into a 
diagnostic image with CMR. However, reality is somewhat more complicated, and in practice 
several RF pulses and gradients are played out in what is known as a pulse sequence, that can 
be varied in order to depict a certain tissue property or physiological response. In order to 
fully understand the coming sections, let us go through some important parameters.  
• Flip angle (FA) – the angle the magnetization is flipped by an excitation pulse. 
• Repetition time (TR) – the time elapsed from one excitation pulse to next. 
• Inversion time (TI) – the time from an inversion (180°) pulse to the excitation pulse.  
2.1.4.1 𝑇"-weighted imaging 
Image acquisition parameters in a pulse sequence can be selected to enhance the contrast 
between particular types of tissue. A short TR time allows for water and fat to be 
distinguished [38]. This is due to that the longitudinal magnetization (𝑇" ) in fat recovers 
faster than it does in water, subsequently this affects the contrast in 𝑇"-weighted images.  
LGE is a 𝑇"-weighted imaging technique that utilizes the difference in distribution of an 
extracellular contrast agent in normal compared to non-normal myocardium. Late refers to 
the fact that the images are acquired at least 10 minutes after contrast administration so that 
the contrast agent has had adequate time to exchange between tissue and blood, achieving a 
dynamic equilibrium. LGE has become the non-invasive reference standard to visualize and 
diagnose myocardial cell damage. Gadolinium coupled with diethyelene triamine pentaacetic 
acid (DTPA) or other similar molecules are referred to as extracellular contrast agents that 
affect the magnetic properties of the tissues they distribute within. The main effect of the 
contrast agent is to markedly reduces 𝑇"values, and thus tissues that have a higher 
extracellular space will appear brighter on 𝑇"-weighted images.  
One way of producing strong 𝑇" contrast is to use an inversion recovery pulse sequence, 
which can null a tissue with a particular 𝑇" -time depending on the TI. Clinically, a trial-and-
error based methodology is typically used to determine TI for LGE imaging. The operator 
acquires images with different TIs with a Look-Locker sequence, called TI scout (Figure 2.4). 
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These images are visually inspected and the operator chooses the TI when it is perceived that 
the myocardial signal is “nulled”, i.e. the myocardium is as black as possible.  
 
Figure 2.4. Illustration of inversion recovery (ms) in TI scout. Numbers in the left corner 
denote TI in ms. Note how the image contrast differs across the different TIs, both in blood 
and myocardium. The TI scout aims to identify where the normal myocardium is nulled, and 
appears black. In this particular instance, this happen somewhere around 310-330 ms. If TI 
was set to 270-290 ms this would be too early, and the myocardium would appear white and 
with little contrast between blood and myocardium. A TI of 350-410 ms would be too late, the 
myocardium is too bright, almost grey, and it would be more difficult to separate the 
endocardium from the blood pool, thus limiting the possibility to identify subendocardial 
myocardial damage.  
2.1.4.2 𝑇" mapping 
Instead of merely producing a 𝑇"-weighted image, a technique to quantitatively image and 
measure the longitudinal relaxation time called parametric pixel-wise mapping has been 
developed [39]. The 𝑇"mapping technique inverts the magnetization (flips the magnetization 
by 180°) by using an inversion recovery (IR) sequence and during the relaxation process, 
images are acquired at multiple time points (TIs). The images are acquired in late diastole and 
during an end expiration breath hold. A commonly used 𝑇"mapping technique is called 
modified Look-Locker inversion recovery (MOLLI) (Figure 2.5) [39]. The technique samples 
the recovery of longitudinal magnetization after inversion, the IR curve. Signal intensity over 
time is used to plot the longitudinal relaxation curve. When the curve is plotted for each pixel 
in the image, we can solve for 𝑇", and 𝑇"can be displayed as a pixel-wise 𝑇"map. In the 𝑇"map, 𝑇"in milliseconds is encoded in the intensity of each pixel. This allows for 
standardized cut-off values for inter- and intra-patient evaluations. 
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Figure 2.5. Illustration of the modified Look-Locker inversion recovery (MOLLI) 
scheme. The schematic displays the original MOLLI protocol used to perform cardiac  𝑇"	mapping. The top figure shows three 180° inversion recovery curves, and the vertical 
black lines signify readout pulses, which corresponds to end diastole as seen in the ECG 
curve below. In total, there are three inversions and eleven readouts, and each readout is an 
image slice acquisition. The time between the inversions and the recovery period are decided 
by the number of heart beats. The results from the readouts are displayed in the image series 
below the ECG, which are ordered by inversion times. The pixel-wise relaxation curves from 
different inversion times are used to estimate 𝑇" relaxation times and create a map where 
every pixel in the image corresponds to a specific 𝑇" value measured in milliseconds. 
Reproduced from [25]. 
2.1.4.3 Phase contrast velocity encoded CMR 
Phase contrast velocity encoded CMR is based on that intravascular spins moving along a 
gradient of a magnetic field will acquire a phase-shift that is directly proportional to flow 
velocity [40, 41]. By measuring the phase, flow velocity can be derived [42, 43]. By applying 
first-order gradient moment nulling, or flow compensation, preservation of the phase from 
areas with flow is ensured. The gradients are then slightly modified to introduce a known 
phase shift in the spins flowing along this gradient [42-44]. This is known as velocity 
encoding, which verifies that certain flow velocities are represented by a corresponding phase 
shift. Since the phase shift is introduced along the velocity encoding gradients, it is worth 
noting that velocity mapping measures velocity with the respect to the image plane (through-
plane velocity), and not velocity in relation to the vessel wall. By subtracting a flow-
compensated and a flow-sensitized image, the only remaining phase difference should be due 
to velocity. However, due to other factors such as eddy currents, additional phase shifts can 
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be present and causes errors in the velocity measurements. Therefore, correction of zero-
phase offset can be performed, in order to ensure accurate display of the flow velocity across 
the imaging plane. By measuring the phase error in static tissue this can be subtracted from 
the flow velocities, and this is known as stationary tissue background correction. There are 
both linear and quadratic stationary tissue background correction methods. The linear 
correction method assumes that the phase offset errors are spatially dependent in a linear 
fashion. The method fits a flat surface via the time average of stationary pixels in the 
velocity-encoded phase images, and the fitted surface is then subtracted from the velocity 
images. The quadratic correction method performs the fitting of the stationary pixels with a 
second-degree polynomial assumption. How is stationary tissue identified? Clinically 
automatic, and semi-automatic methods with manual adjustments are used. The automatic 
methods identify stationary pixels by a predefined value of the phase deviation over time. The 
manual adjustments are then employed to include visual static tissue, which can be achieved 
by changing the threshold for phase deviation and/or by placing a region of interest (ROI) in 
tissue that should either be included or excluded.  
2.1.4.4 Perfusion imaging 
Myocardial perfusion can be imaged with CMR by utilizing the dynamic inflow of a bolus of 
contrast agent. In current clinical practice, a visual assessment of the inflow is used to 
diagnose the presence of coronary disease. Semi-quantitative techniques have been proposed 
to mitigate the qualitative assessments, however a quantitative evaluation would be even 
more desirable. A quantitative perfusion mapping sequence has recently been developed and 
implemented a fully automated post processing tool using the Gadgetron framework [45]. 
This technique uses what is known as a dual sequence approach to first pass perfusion. A 
saturation recovery sequence acquires images at baseline and continuously throughout the 
first pass of contrast through the myocardium. Low resolution blood pool images are acquired 
with a fast low angle shot (FLASH) readout, and high resolution images are acquired with a 
balanced steady state free precession (bSSFP) readout (Figure 2.6). The saturation 
preparation consists of six non-selective RF pulses where the FAs are tailored by applying 
gradient spoilers for separation. These images go through extensive post processing for 
motion correction, identification of the arterial input function, signal intensity normalization 
and conversion to gadolinium concentration units, deconvolution, and blood flow estimation 
before finally rendering quantitative pixel-wise color maps of myocardial perfusion [45]. 
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Figure 2.6. Schematic representation of the myocardial perfusion imaging sequence. The 
top row shows dual sequence image acquisition in relation to the electrocardiogram (ECG). 
The first image is the low resolution arterial input function (AIF) acquisition with the RF 
pulse scheme below the ECG. The following images are high resolution myocardial 
acquisition with the RF pulse scheme at the bottom. The images to the right show the 
reconstructed images, at the top the low resolution, AIF image, and at the bottom the high 
resolution, myocardial image. Reproduced from [45]. 
2.2 𝑻𝟏 MAPPING, ACCURACY AND PRECISION 
Native myocardial 𝑇" mapping has been validated for a comprehensive set of cardiac 
pathologies such as myocardial infarction [46, 47], myocarditis [47, 48], amyloidosis [49], 
Anderson-Fabry disease [50], and iron overload [51], and allows for quantitative 
measurements of tissue characteristics.  
The first pixel by pixel 𝑇"mapping sequence (MOLLI) was introduced by Messroghli, et al. 
[39] and propelled the CMR field to move from LGE as the primary method of tissue 
characterization. The field has since been exploring the potential of non-contrast tissue 
characterization using 𝑇"mapping. As previously described, 𝑇" mapping samples the IR curve 
by acquiring multiple images at different TIs to produce a pixel-wise map via curve fitting of 
the measured values. The TIs are sampled with single shot imaging spaced by the heart beat 
intervals. In order to acquire the IR curve more evenly, multiple inversions with different 
trigger delays are employed. This ensures that samples from the entire IR curve are acquired. 
Multiple inversions introduce a need for a waiting period, to ensure that the magnetization 
will reach the initial equilibrium. Otherwise, the TIs would be acquired from different 
recovery curves and compromise the 𝑇"accuracy and precision. The precision of the 𝑇"	map 
is therefore linked to the number and the positions of the acquired TIs. The number of 
acquisitions also affects the accuracy of the 𝑇"	map, as the readout influences the apparent 
recovery, which affects the signal model used to produce the 𝑇"	map.  
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2.2.1 Accuracy 
The readout used in MOLLI is called steady state free precession (SSFP). SSFP causes the 
inversion to recover faster and to reach a steady state that is less than the initial 
magnetization. The time constant describing this sampled recovery curve is referred to as 𝑇"*, 
an apparent recovery time constant. The apparent time constant, 𝑇"*, is less than the actual, 
desired tissue parameter 𝑇". To adjust for this accuracy problem the measured values are 
fitted using an exponential signal model with three parameters. The signal model is described 
by the equation S(t) = A – Bexp(-t/𝑇"*), where t is the inversion time, and 𝑇"* is the apparent 𝑇". 𝑇" is approximated using 𝑇" ≈ 𝑇"*(B/A-1), and this is called “Look Locker” correction. 
However, the apparent 𝑇"* shortening is 𝑇,-dependent, due to the SSFP readout [52, 53]. 
This means that the 𝑇"	map has a slight 𝑇,-weighting. The 𝑇, dependent error is also 
increased by imperfect inversion efficiency, however this can be minimized by using an 
inversion pulse with a short duration [54]. The 𝑇,	dependency is not all bad, as a 100% 
increase in 𝑇, will result in a 4% increase of the 𝑇"*. For example, in tissues with edema with 
both increased 𝑇"	and 𝑇,, the 𝑇"* elevation will be slightly higher, thus improving 
detectability [25]. However, the 𝑇, dependency also leads to that 𝑇" mapping using SSFP 
readouts is sensitive to heart rate and off-resonance effects.  
2.2.1.1 Off-resonance effects 
Off-resonance will cause banding artifacts when using the SSFP readout, which is visually 
apparent to the clinician. However, small off-resonance frequencies that will not cause visual 
banding artifacts, can still result in a significant error in the 𝑇" estimate [55]. Regional 
variation in the 𝐵& field that surrounds the heart cause regional variations in 𝑇" that in fact are 
artifacts. Off-resonance related errors can be reduced by reducing the FA, however, this 
comes with the cost of lower precision due to a noisier map [25].     
2.2.1.2 Heart rate dependency  
The heart rate dependency when using MOLLI is related to two major factors 1) the time 
between inversions and 2) the SSFP readout influence on each inversion recovery. By 
changing the order of the inversions in the acquisition protocol, the time between inversions 
can be increased. The SSFP readout effect can be mitigated by reducing the number of 
inversions. The (3(3)3(3)5) original MOLLI protocol acquired 11 images in 17 heart beats 
using 3 inversions, and the recovery time between inversions was set to 3 heart beats. It is 
easy to understand that with higher heart rate, the inversion curves do not fully recovery 
during 6 heart beats (acquisition + recovery). Thus, the magnetization does not reach initial 
magnetization equilibrium before the subsequent inversion pulse. Therefore, the 5(3)3 
protocol was introduced, to acquired 8 images in 11 heart beats using 2 inversions with the 
time between inversion set at 8 heart beats [46]. This protocol improved heart rate sensitivity 
by starting with 5 acquisitions during the first 5 heart beats, followed by a recovery time of 3 
heart beats. However, the 5(3)3 protocol was further modified to set the time between 
inversion in seconds (5(3s)3), which furthered mitigated heart rate dependency [56]. By 
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adjusting the protocol to determine both acquisitions and time between inversion in seconds, 
and not heart beats, a more complete recovery at high heart rates is ensured (5s(3s)3s) [25].  
Another strategy to deal with the heart rate dependence, known as ShMOLLI, was introduced 
in 2010 [57]. The (5(1)1(1)1) protocol acquires 7 images in 9 heart beats during 3 inversions, 
and performs conditional fitting. This means that in pixels with long 𝑇"measured during a 
short RR interval, data will be refitted using only the first 5 measurements acquired during 
the first inversion. The protocol reduces heart rate dependency, however it also introduces a 
loss of precision associated with discarding data.  
2.2.1.3 A new approach for absolute accuracy 
An alternative to IR is saturation recovery (SR). With SR approach, each recovery becomes 
independent of the others, and recovery periods become obsolete. Therefore, saturation 
recovery single shot acquisition (SASHA) was developed [58]. Similarly to the MOLLI 
protocol, multiple time points are obtained however SASHA acquires images of the 
saturation recovery curve and performs a pixel-wise curve fit (Figure 2.7). The SR curve 
recovers according to 𝑇" relaxation, but the magnetization recovery is not as influenced by 
the SSFP readout as the IR curve. This eliminates several sources of inaccuracies compared 
to IR techniques as no correction of the 𝑇"* has to be performed. Therefore, SASHA has a 
better accuracy compared to MOLLI-based techniques. However, SASHA is acquired with a 
higher FA and the SSFP readout slightly alters the shape of the saturation curve. This is 
accounted for with either a 2- or 3-parameter signal model, which adds an issue of loss of 
precision [25].  
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Figure 2.7. Scheme of saturation recovery single shot acquisition (SASHA) protocol. 
This schematic displays the SASHA protocol for cardiac  𝑇" mapping. The scheme starts with 
a single image acquisition without saturation and followed by image acquisitions at different 
saturation recovery times (TSi), indicated by the black vertical lines. To ensure mid- to end-
diastolic imaging are all the images acquired using an equal delay from the R-wave rigger 
(TD). The different TSi are used to plot a T1 relaxation curve and a pixel-wise fit is 
performed to produce a 𝑇"	map where every pixel value in the image corresponds to a 
specific 𝑇"	time measured in milliseconds. Reproduced from [25]. 
2.2.2 Precision 
The original MOLLI scheme has excellent precision, however the accuracy degrades with 
higher heart rates [39]. The MOLLI 5(3s)3 also has excellent precision, and the accuracy is 
less heart rate sensitive. The 5s(3s)3s MOLLI scheme has the same precision as the 5(3s)3 at 
heart rate 60 beats per minute, but with the advantage of a higher precision at higher heart 
rates. The ShMOLLI scheme discards data and sacrifices approximately 30% in precision 
without a gain in accuracy [25]. Precision can be improved furthered in the MOLLI schemes 
by using phase sensitive inversion recovery (PSIR) reconstruction. The precision of MOLLI 
is increased with around 30% using PSIR reconstruction compared to multi-fit magnitude 
inversion recovery fitting [59]. SASHA acquired during a breath hold duration identical to a 
MOLLI 5(3s)3 protocol will have a higher accuracy, however a degraded precision compared 
to the MOLLI protocol. The loss of precision is around 35% for SASHA with a 2-parameter 
fit compared to 5(3s)3 MOLLI. With SASHA using the 3-parameter fit the loss of precision 
is 125% compared to 5(3s)3 MOLLI with 3 parameter fitting [25].  
2.2.3 Improving 𝑻𝟏	mapping 
Different approaches to optimize 𝑇" mapping include changes in the imaging protocol to 
circumvent heart rate dependency and reduce the duration of breath hold [57, 60], motion 
correction to reduce the effect of respiratory motion for patients with poor breath holding 
[59], PSIR reconstruction to improve measurement precision [59], and saturation based 
techniques for higher accuracy [58]. However, as we learn more about the factors influencing 
the accuracy and precision of 𝑇"	mapping [61] new areas of improvements arise such as 
blood correction, and the potential use of 𝑇"	mapping for scar imaging.  
2.2.3.1 Blood correction 
Approximately 4-5% of the left ventricular stroke volume in healthy humans enters the 
coronary arteries and perfuse the myocardium [62]. The 𝑇"	value of blood is much higher 
(around 1400-1700 ms) than the 𝑇"	value of myocardium (900-1100 ms), shown in our own 
data at 1.5 T. Since the myocardium contains blood, the myocardial  𝑇"	value is likely to be 
influenced by the 𝑇"	values of this blood volume. Thereby, 𝑇"	value of the intramyocardial 
blood may obscure the true 𝑇"	values of the cardiomyocytes. Since different diseases may 
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influence both the amount of blood in the myocardium, but also the 𝑇" value of blood, these 
processes might weaken clinical diagnosis based on 𝑇" mapping.  
The partial volume effect is the concept that a one voxel might comprise of different tissues, 
or a tissue of different features, where the pixel value for the voxel reflects the average of 
these contents [63]. Furthermore, the myocardial 𝑇" values reflect a tissue consisting of 
cardiomyocytes, extracellular connective tissue, signal transductions connections, blood 
vessels with blood inside [64, 65]. Therefore, myocardial 𝑇" values, should be related to the 
entire composition of this tissue, which also includes the microcirculation. The blood  𝑇" 
values vary due to several factors such as hematocrit [66], HDL cholesterol, iron [67], pH, 
temperature, sex [60], age [68] and oxygen pressure [66, 69]. Variations in these different 
characteristics may therefore influence the evaluation of myocardial 𝑇" values. Several 
approaches for correcting the myocardial 𝑇" values for blood 𝑇" values have been reported 
[70, 71]. Reiter, et al. [71] eliminated age and sex differences when correcting myocardial 𝑇" 
values, for 𝑇" values measured in the LV blood pool. Therefore, performing blood correction 
could increase the precision of native myocardial 𝑇" values between patients. This could 
furthermore improve the accuracy of clinical 𝑇"mapping and reduce the sample size needed 
for clinical research. However, it is unknown which parameter to use for blood correction, 
and furthermore any potential blood correction model needs to be validated in a separate 
cohort.  
2.3 DIAGNOSTIC PRECISION IN FLOW QUANTIFICATION 
CMR flow quantification for determining the ratio of flow between the pulmonary and 
systemic circulation (Qp/Qs) is used to quantify cardiac shunts. However, measurement 
errors may influence both the accuracy and precision of the flow quantification. Therefore, 
post-processing corrections algorithms have been proposed to reduce measurements errors 
[21]. These methods include both linear and stationary tissue background correction, which 
have not been evaluated systematically, and it is currently not known how the correction 
algorithms affect clinical precision and accuracy. In the clinical setting, there are different 
software implementations in use. However, how these software products perform with 
regards to precision and accuracy is unknown. It is therefore of importance to elucidate 
whether the clinical software algorithms actually improve clinical evaluation, and 
furthermore understand how they perform in relation to each other. Also, a number of patient 
characteristics might influence the background correction such as body surface are or image 
angulation. The different characteristics need to be investigated for changes in accuracy and 
precision of Qp/Qs after background correction, in order to understand which patient benefits 
from stationary tissue background correction. 
2.4 IMAGING OF FOCAL LESIONS 
Myocardial cells are irreversibly damaged during an acute myocardial infarction when they 
lose their cellular integrity after cell membrane rupture [72]. Intravenous injection of 
gadolinium distributes into the extracellular space of what before an acute myocardial 
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infarction, would have been the intracellular space of cardiomyocytes [73, 74]. Furthermore, 
gadolinium distributes in the extracellular space of tissues with increased amount of 
extracellular matrix or fluid [35] Therefore, the LGE sequence can be used to visualize non-
ischemic diseases with either fibrosis, or high-grade inflammation. Gadolinium enhances the 
contrast of the damaged tissue from the normal myocardium, and LGE images will visualize 
focal myocardial fibrosis, regardless of its origin (Figure 2.8). The underlying etiology can be 
determined from the pattern of enhancement, since the ischemic focal myocardial fibrosis 
involves the subendocardial layer of the LV myocardium and is restricted to the perfusion 
territory of the relevant coronary artery. Epicardial focal fibrosis that does not include the 
endocardial layer can be caused by several infectious, inflammatory and other myocardial 
pathologies [13]. 
 
Figure 2.8. The gadolinium enhancement in different disease states. Simplified schematic 
illustration of gadolinium distribution in different tissues, and how this appears in LGE 
images. The top row shows images of the cellular tissue level. The bottom row shows 
corresponding LGE images. The left panel shows normal myocardium with intact cell 
membranes. The middle panel shows an acute myocardial infarction (MI) with cell 
membrane rupture. The right panel displays an inflammatory disease with a fibrotic collagen 
matrix. Notice the pattern of enhancement in the middle picture; an acute myocardial 
infarction with transmural extent, distributed from the endocardium to the epicardium in the 
septum. The right LGE image illustrates a non-ischemic disease, sparing the endocardium, 
with only epicardial focal fibrosis. Both myocardial lesions of the middle and right images 
involve the septal part of the myocardium, the wall between the right and left chambers, 
separating the blood pools from each other. Adapted from [75]. 
However, the TI that needs to be set for LGE acquisition differs between patients and even in 
the same patient over time, due to renal clearance of the contrast agent, differences in contrast 
dose, the time elapsed after intravenous contrast administration, the habitus of patient’s body 
and cardiac function [76]. This inherent methodological factor can become a challenge during 
clinical imaging. The LGE image is dependent upon relative differences in signal intensities 
between focal myocardial damage and normal myocardium [77, 78]. However, diffuse 
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fibrosis may be missed by LGE, since the signal intensity may be close to isointense, which 
causes all the diseased myocardium to be nulled and perceived as healthy myocardium. The 
clinical evaluation of these images, and the patient’s diagnosis is dependent on the observer’s 
visual discriminative ability.  
Quantitative 𝑇"	mapping can be used to detect both focal and diffuse myocardial pathologies 
[48, 49, 79]. Myocardial 𝑇"	values that are measured following the injection of gadolinium 
can convey information about both focal myocardial fibrosis, but also additional information 
about the extracellular volume fraction (ECV) though the production of ECV maps [46, 80]. 
Notably, it is not possible to quantify ECV using LGE images. Post-contrast 𝑇"	maps may be 
used to appreciate the expansion of the myocardial extracellular space [39]. However, post-
contrast myocardial 𝑇"	values vary according to the injected dose of contrast, renal clearance, 
time of acquisition, body composition and hematocrit, like in the case with LGE [75]. 
Therefore, myocardial 𝑇"	values measured post-contrast for distinguishing diseased from 
normal myocardium suffers from limited precision [81]. However, synthetic LGE (SynLGE) 
images can be generated using post-contrast 𝑇"	maps, with an image contrast similar to 
conventional LGE images. Both post-contrast 𝑇"	maps and LGE images are currently 
acquired during a clinical scan. If SynLGE images visually provide the equivalent diagnostic 
information regarding focal myocardial fibrosis compared to LGE, LGE acquisition could be 
omitted from the examination. However, it is currently unknown if SynLGE can provide 
equivalent diagnostic information regarding focal myocardial fibrosis compared to 
conventional LGE. Furthermore, the sensitivity and specificity of SynLGE compared to 
conventional LGE in terms of detecting focal myocardial fibrosis need to be investigated, 
which we performed in Study IV. 
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3 DIFFERENCES IN CARDIOVASCULAR DISEASE 
BETWEEN THE SEXES 
Over the last 20 years, mortality in cardiovascular disease in Sweden has been cut in half. 
However, this reduction has been more pronounced in men than in women [82]. Some 
diseases have a higher prevalence in women, including myocardial infarction with non-
obstructive coronary arteries (MINOCA), Takotsubo cardiomyopathy but also pulmonary 
hypertension [83]. Differences between the sexes in cardiovascular disease are multifactorial, 
and include both gender- and sex-related factors.  
3.1 SEX DIFFERENCES IN CARDIOVASCULAR PHYSIOLOGY 
Several differences in the cardiovascular system between women and men exist. Men have 
higher cardiac output, an average of 5.6 l/min, compared to women, with an average cardiac 
output of 4.9 l/min [62]. However, when accounting for body surface area by using the 
measurement cardiac index the sex differences disappears [84]. The cells that enables 
transport of oxygen to the body are called red blood cells (RBC), and contain hemoglobin. 
The average number of RBCs per mm3 of blood in men is 5 200 000 (±300 000), whereas in 
women it is 4 700 000 (±300 000). The amount of hemoglobin (the molecule that binds 
oxygen in the RBCs) also differs between the sexes. Whole blood in men contains on average 
15 g of hemoglobin per 100 ml of cells, which is slightly lower in women, with an average of 
14 g per 100 ml of cells. One gram of hemoglobin can carry 1.34 ml of oxygen. This means 
that a healthy man can carry a maximum of 20 ml of oxygen per 100 ml of blood, whereas a 
woman can carry 19 ml of oxygen per 100 ml of blood at maximum [62]. Furthermore, 
younger women have higher heart rate compared to men. The heart rate variability is also 
higher in women compared to age-matched male controls. However, the differences between 
the sexes disappears in their fifties [85]. The heart rate variability decreases with age, 
however, this decrease in more pronounced in men. A difference in heart rate variability in 
women can only be seen when comparing the youngest (10-29 years) to the oldest (70-99 
years) [85]. Women’s hearts also have a smaller mass compared to men, as well as lower 
volumes [86, 87]. 
3.2 ISCHEMIC HEART DISEASE  
Ischemia is defined as an insufficient blood supply to a tissue in relation to demand, and 
thereby not fulfilling the need for oxygen in the specific tissue. Ischemia is usually caused by 
a restriction of the blood flow, and in the coronary arteries specifically, it can be caused by a 
complete blockage (occlusion) or a reduction in blood flow (stenosis). The underlying 
pathology for ischemia in the heart is usually an atherosclerotic process within the coronary 
arteries, causing a narrowing of the vessel which eventually restricts flow of blood to the 
heart muscle downstream from the affected site [88]. This narrowing, the atherosclerotic 
plaque, may rupture, exposing the underlying layer, which causes a blood clot to form on site, 
that completely blocks the coronary artery [89]. This complete blockage causes acute 
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myocardial ischemia. If this blockage is not resolved, prolonged ischemia will progress to 
irreparable cell death within 2-4 hours, and the formation of a myocardial infarction over the 
course of 5-6 weeks [72]. It is known that the degree of atherosclerotic obstruction does not 
predict the risk of plaque rupture, and it is possible to develop complete coronary occlusion 
and consequent acute myocardial infarction (AMI) without any preceding symptoms [90, 91]. 
Thereby, a stenosis does not always rupture, instead it can progress continuously until it 
restricts blood flow when the oxygen demand is increased i.e. during physical activity [92]. 
Ischemic heart disease has therefore historically been divided into two subgroups: acute 
ischemic heart disease and stable ischemic heart disease.  
3.2.1 Sex difference in acute ischemic heart disease 
Around 30 000 people are diagnosed with AMI every year in Sweden. A third of those 
diagnosed with AMI are women. The average age for men that are being treated for an acute 
myocardial infarction at the coronary care unit (CCU) is 71 years, whereas it is 77 years for 
women. In women with AMI, it is more common that there is no significant stenosis or 
completely normal coronary arteries present when undergoing angiography. This is called 
MINOCA (myocardial infarction with non-obstructive coronary arteries) and MINCA 
(myocardial infarction with normal coronary arteries). Even though the most common 
pathology for AMI is obstructive atherosclerotic plaque there are atherosclerotic plaque that 
can hide in the vessel wall [93], and these plaques can erode (bleed) [94, 95]. Plaque-erosions 
are more common in women, and it has been speculated that this may cause distal clotting, 
which could be a possible pathogenesis for MINOCA [96].  
A difference between the sexes that is likely gender related is the difference in symptom of 
acute ischemic heart disease. The most common symptom of AMI is central chest pain that 
can spread to the left arm or both arms, to the neck and jaw and sometimes to the back. 
However, 40% of all women with ACS (AMI and instable angina) do not present with chest 
pain. Instead they experience other symptom such as shortness of breath, nausea and fatigue. 
Women with ACS more often than men experience several symptoms, making the chest pain 
seem less prominent.  
3.2.1.1 Sex differences in diagnosis of acute ischemic heart disease 
Acute ischemic heart disease is also called ACS, and has historically comprised of three 
clinical manifestations: ST elevation myocardial infarction (STEMI), non ST elevation 
myocardial infarction (Non STEMI) and unstable angina. The terms ST elevation and non ST 
elevation originate from how the myocardial ischemia manifests on the electrocardiogram 
(ECG). ECG is a cheap, fast, and highly accessible test to determine the presence of 
myocardial ischemia, and therefore one of the major sub classifications of acute ischemic 
disease is based on the appearance on the ECG. The term angina originates from angina 
pectoris, which means chest pain, and has become a common term to describe chest pain of 
cardiac origin.   
  27 
• ST elevation myocardial infarction (STEMI) originates from the relative rise in the so 
called ST-segment in the normal ECG, which is located between the S-wave and T-
wave. An ST elevation is a sign of transmural ischemia due to occlusion of a coronary 
artery. If left untreated, the ischemia will developed into a myocardial infarction [97]. 
• Non-ST elevation myocardial infarction (Non STEMI) includes all aspects of 
myocardial cell death caused by ischemia with no ST-segment elevation present on 
the ECG. Inherently this includes a broad spectrum of small ischemic injuries to 
severe ongoing myocardial ischemia [98]. 
• Myocardial ischemia that induces symptoms but not cell death is called stable or 
unstable angina. Clinically, these are separated from manifestations causing cell death 
(STEMI/Non STEMI) by biomarkers of myocardial cell death in the patients blood 
(troponins), whereas stable and unstable angina are differentiated via the character of 
the symptoms [98]. 
The criteria for diagnosing AMI is an increase and dynamic response in biomarkers of 
myocardial cell death (troponins) together with at least one of the following criteria [72]: 
• Typical symtoms of myocaridal ischemia (acute chest pain) for more than 15 
minutes, or lung edema without any other plausible explanation.  
• Pathological Q-wave in the ECG. 
• Newly developed changes in the ECG associated with myocardial ischemia (i.e. ST 
elevation or depression) 
• Signs of myocardial cell death or regional wall motion disturbance with cardiac 
imaging.  
Men tend to have higher levels of troponins compared to women [99], which could be a 
reflection of their increased myocardial mass [100]. This sex difference could be a reason to 
have separate cut-off values for males and females in order to increase diagnostic precision, 
however, there is currently no consensus [101]. 
There are different cut-off values for men and women to define an ST elevation using the 
ECG. For women, a 0.15 mV in the leads V2-V3, and 0.1 mV in the other leads are deemed 
an ST elevation. However, for men, the cut-off values depend on age, where young men 
(under 40 years old) can have up to a 0.25 mV elevation in leads V2-V3. However, in older 
men (over 40 years old) only 0.2 mV in leads V2-V3, and 0.1 mV in the other leads is 
deemed an ST elevation.  
3.2.2 Sex differences in stable ischemic heart disease 
The most common symptom of CAD is chest pain during physical exertion, also known as 
angina. However, approximately one-third of symptomatic patients do not have obstructive 
CAD [102]. Nevertheless, these patients may suffer from substantial myocardial ischemia, 
with a poor prognosis [103]. Historically all diagnostic tests for CAD, regardless if they are 
anatomical or functional, have been developed for the purpose of identifying obstructive 
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CAD, and have been validated against the coronary angiogram. Given that the clinical focus 
has been directed towards obstructive CAD, there is now a lack of clinical evidence and 
knowledge on how to identify and manage patients with angina without obstructive CAD. 
The first step to bridge this gap is to adopt a unifying terminology. The following 
terminology has been purposed by Colin Berry [104]: 
Ischemic heart disease includes: 
• Stable coronary symdrome 
o Obstructive CAD 
o Ischemia and no obstructive coronary artery disease: INOCA 
• Acute coronary syndrome 
o STEMI 
o Non STEMI/unstable angina 
o Myocardial infarction with non-obstructive coronary arteries: MINOCA 
The following section on sex difference in stable coronary syndrome will reflect that the 
current knowledge on INOCA, which is also referred as microvascular dysfunction, is sparse, 
and that the clinical focus has been on obstructive CAD. 
The most common symptom of obstructive CAD is angina during physical exertion. 
However, there are also atypical symptoms including shortness of breath, nausea and fatigue. 
Women and older patients more often present with what is called atypical symptoms, making 
it less likely that the clinician will suspect CAD as the primary cause. A gender aspect of 
symptoms is that women tend to describe their symptoms as a more diffuse pressure, and not 
as chest pain [105].  
3.2.2.1 Sex differences in diagnosis of stable coronary syndrome 
There are several diagnostic tests to determine if a patient with chest pain suffers from 
obstructive CAD. The current guidelines of stable CAD recommend basic testing in the form 
of ECG at rest, blood samples and echocardiography [106]. In patients with normal LV 
function, the continuing course of action is dependent upon the PTP. Patients with 
intermediate risk (15-85%) are candidates for non-invasive testing, where patients in the 
lower interval are candidates for exercise testing or CCTA, whereas patients with higher risk 
(66-85%) are eligible for non-invasive imaging including stress echocardiography, SPECT, 
PET or stress CMR depending on local availability and expertise. Patients with high risk 
(over 85%) should be assessed with an invasive angiogram, and not wait for a non-invasive 
test.  
Exercise test 
The exercise test, in Sweden, is usually conducted on a bicycle ergometer, with the intent to 
physiologically induce myocardial ischemia. Several parameters are evaluated during an 
exercise test such as symptoms, maximum work capacity, ST changes and hemodynamic 
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response. Exercise-induced angina in women does not predict future coronary events, and is 
as common in women with no obstructive CAD as in women with triple vessel disease [101]. 
However, the angina may be due to INOCA, and may therefore be missed by the anatomical 
assessment with an angiogram.   
The reference values for men and women are different for maximum work capacity, where 
men are expected to perform at a higher level compared to women. Furthermore, work 
capacity decreases with age. Therefore, the work load has to be adjusted for every patient, 
and women more often start on a lower workload compared to men.  
Evaluating the ST reaction can pose a challenge in women due to preexisting disturbances in 
the ST region. There are several contributing factors such as the presence of breast tissue, 
estrogen levels and valve anomalies. A recent study that compared CCTA to exercise testing 
in women showed that exercise testing failed to identify obstructive CAD in over half of the 
patients [107]. 
SPECT 
SPECT is NM technique where a radioactive isotope tracer is injected into a vein (blood 
vessel), both at rest and during stress (exercise test or with pharmacological stressors). The 
tracer used for myocardial perfusion imaging will follow the blood stream to the heart, where 
it is taken up in mitochondria in the myocardium. The parts of the myocardium that are not 
perfused by blood will appear as a perfusion defect when the images of tracer distribution are 
acquired. If there is a fixed defect (the defect is present both at rest and stress) it is likely due 
to a myocardial injury, such as a myocardial infarction. A reversible defect (present during 
stress, however not during rest) is most likely due to obstructive CAD. There is a risk that 
breast tissue in women induces an artifact that can be perceived as a defect. SPECT has a 
high sensitivity for single vessel disease, which is more common in women, however, 
SPECT cannot identify balanced ischemia or INOCA.  
Stress echocardiography 
Myocardial ischemia is identified as decreased wall motion, or contractility, at 
echocardiography during stress. Stress can be induced by physical exertion or 
pharmacological stress, most commonly using dobutamine. Stress echocardiography is 
known to be highly operator dependent.  
CT 
There are two ways to use CT for detecting CAD, one is the calculation of coronary 
calcification [4] and the other by performing a contrast-enhanced CCTA [5]. Increased 
coronary calcification increases the risk for future adverse cardiac event, such AMI. The 
method has a high sensitivity for detecting atherosclerosis, however the specificity for 
identifying obstructive CAD is low. CCTA provides anatomical information such as plaque 
morphology but also degree of obstruction. It has a high NPV and therefore, in the UK it is 
 30 
recommended to perform CCTA as the first-line of diagnostic tests in angina patients without 
prior coronary disease [108]. However, a CCTA strategy does not increase quality of life nor 
decrease symptoms compared to standard care [109]. Furthermore, CCTA does not provide 
information on microcirculation, and therefore inherently lacks the ability to identify patients 
with INOCA.  
PET 
PET detects the first-pass perfusion of radioactive tracers with high first-pass extraction and 
use time-intensity curves and different tissue compartment models to quantify absolute 
myocardial perfusion (ml/min/g). Myocardial perfusion at rest and stress is used to calculate 
CFR which can be used for both identification of coronary stenosis and microvascular 
dysfunction [110]. The main disadvantages of PET are limited spatial resolution, ionizing 
radiation and clinical availability. 
3.3 SEX DIFFERENCES IN PERFUSION USING CMR 
Obstructive CAD and several non-ischemic heart diseases effect the myocardial 
microcirculation [111]. In order to diagnose obstructive CAD or other diseases that alter 
myocardial perfusion, imaging techniques using pharmacological stressors have been 
developed [112]. PET is the current reference standard for quantification of myocardial 
perfusion in ischemic heart disease [113]. However, CMR has potential advantages over PET 
since it is a method free of ionizing radiation, has better spatial resolution, and is more widely 
available. CMR can quantitatively measure myocardial perfusion and MBV at rest and during 
pharmacological stress [20, 113, 114]. However, several CMR approaches for assessing 
perfusion and MBV exist, including contrast enhanced first-pass perfusion imaging, phase 
contrast velocity-encoded coronary sinus flow (CSF) measurement, 𝑇" mapping and ECV 
imaging, before and during adenosine stress. Decreased MBV reserve during 
pharmacological stress has been shown to be proportional to the severity of a stenosis of a 
coronary artery [20, 115]. Recent developments allow for quantitative assessment of 
myocardial perfusion and myocardial blood volume using CMR [45]. The ability to quantify 
absolute myocardial perfusion allows for quantification of CFR, which potentially can be 
used to identify INOCA, as well as obstructive CAD. However, it is important to investigate 
if any sex differences exist in normal physiology, as normal ranges might differ between the 
sexes. It is important to identify any potential differences in order to introduce proper cut-off 
values when moving towards quantification, which will increase both the accuracy and 
precision of a newly developed method.  
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4 AIMS 
The overall aim of this thesis was to identify parameters that affect clinical diagnostic 
precision, as well as sex differences that influence clinical evaluation in a variety of different 
CMR methods.  
The specific aims for each study were: 
1) To investigate the impact of intramyocardial blood on native myocardial 𝑇" 
values. This included identifying which blood parameter that had the biggest 
effect on the myocardial 𝑇" values, constructing a blood correction model, and 
validating the correction model for clinical use. 
2) To evaluate the changes in precision and accuracy following stationary 
background tissue correction in phase velocity encoded CMR flow quantification. 
This included elucidating if any particular parameter such as sex, or hematocrit 
affected the background tissue correction and thereby, could affect the clinical 
interpretation of the pulmonary-to-systemic blow flow ratio. 
3) To explore if sex differences in myocardial perfusion, myocardial blood volume 
and extracellular volume exists 
4) To analyze the diagnostic value of synthetic scar imaging from post-contrast 
myocardial 𝑇"	mapping.  
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5 MATERIALS AND METHODS 
5.1 STUDY POPULATIONS 
In three of the four studies (Study I, II and IV) the study populations consisted of consecutive 
clinical patients referred for CMR at Karolinska University Hospital, Stockholm, Sweden, 
between different predefined dates, which will be described in greater detail below. There 
was an overlap between the study populations of Study I and Study II, where a total of 18 
patients fulfilled the inclusion criteria to be included in both studies. In Study I, a population 
of healthy volunteers from University College London was also included. The study 
population in Study III consisted of a prospective cohort of healthy volunteers from 
Karolinska University Hospital. Ethical approval was granted for all study procedures, and all 
subjects provided written informed consent. 
5.1.1 Study I 
In total, 400 consecutive patients scanned between January 2014 and August 2015 were 
retrospectively enrolled. The goal was to include 200 females and 200 males respectively, 
and the inclusion was terminated when the goal was met. Exclusion criteria and the number 
of excluded patients can be found in Figure 5.1 
Healthy volunteers (n=77) were prospectively enrolled between April 2014 and July 2015. 
The volunteers were included if they had no cardiovascular disease or diabetes.  
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Figure 5.1 Patient population. The flow chart displays patient inclusion, exclusion and final 
constitution of the respective derivation and validation cohorts.  
5.1.2 Study II 
Consecutive patients (n=91) referred for clinical CMR, examined between January and 
September 2014, were retrospectively enrolled. Inclusion criteria included that the clinical 
report had no mention of cardiac shunt or malformations of the great vessels, no persistent 
arrhythmias defined as a standard deviation of the mean R-R interval during flow image 
acquisition exceeding 10% or the R-R interval for either acquisition, and no poor image 
quality due to extensive fold over.   
5.1.3 Study III 
Healthy volunteers (n=43) with no cardiovascular medication, no history of asthma, no 
history of cardiovascular or kidney disease, that were current non-smokers and had a normal 
12-lead ECG were included. Exclusion criteria included failed splenic switch off [116], low 
AIF (<2mmol/l), and poor image quality.  
5.1.4 Study IV 
A total of 109 clinical patients referred for diagnostic CMR assessment of known or 
suspected heart disease between February 2012 and October 2013 were retrospectively 
identified.  
543	patients	
assessed	for	
eligibility	
143	patients	excluded
• Septal	focal	abnormality,	n=66
• Cardiac	shunt,	n=69
• Poor	image	quality,	n=5
• Cardiac	tumor,	n=3
400	patients	included
• Females,	n=200
• Males,	n=200
Derivation	cohort,
200	patients
• Males,	n=100
• Females,	n=100
Validation	cohort,
200	patients
• Males,	n=100
• Females,	n=100
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5.2 IMAGE ACQUISITION AND ANALYSIS 
All patients in Study I, II and IV, and healthy volunteers in Study III were scanned on a 1.5 T 
system (Magnetom Area) with an 18-channel body matrix coil, together with a spine matrix 
coil. All scans were performed with the subject in the supine position. The healthy volunteers 
in Study I were scanned on a 1.5 T system (Magnetom Avanto) in a supine position, with a 
32-channel cardiac phased array receiver coil. Patients in Study I were analyzed using 
SyngoVia VA30 (Siemens), and a clinical work station (ISD7, Sectra). Patients in Study II 
and IV, and healthy volunteers in Study III were analyzed using SyngoVia VA30 and 
Segment (Medviso AB)[117]. Healthy volunteers in Study I were analyzed using CVI42 
software (Circle, Cardiovascular Imaging Inc.).  
5.2.1 Study I 
All patients had acquired native myocardial 𝑇"	maps using a 5(3)3 modified Look-Locker 
inversion recovery (MOLLI) sequence [59]. Native 𝑇"	in the healthy volunteers were aquired 
with a 5s(3s)3s MOLLI protocol. For further details on imaging parameters see Study I.  
One observer acquired native myocardial 𝑇"	values, and blood 𝑇"	and 𝑇"* values from both 
ventricles. The native myocardial 𝑇"	values were manually acquired by placing a ROI in the 
septum in a mid-ventricular short-axis 𝑇"	map. In order to avoid partial volume effect from 
the blood pool the ROIs were conservatively placed in the mid-mural septum. Blood 𝑇"	and 𝑇"* values were acquired with two ROIs in the corresponding 𝑇"	map and 𝑇"* map. Care was 
taken to avoid including papillary muscle and trabeculae (Figure 5.2). Mean blood 𝑇"	and 𝑇"* 
values were calculated and converted to the 𝑇" relaxation rate (R1=1/𝑇"), resulting in mean 
blood R1 and R1* values. 
 
Figure 5.2. The manual delineation of the 𝑇"	and 𝑇"* maps. This figure displays the 
regions of interest (ROI) drawn in the respective short-axis maps. The measurements 
acquired were native myocardial 𝑇"	values, LV blood pool 𝑇"	and 𝑇"* values, and RV blood 
pool 𝑇"	and 𝑇"* values.  
T1	map T1*	map
LV LV
RV
RV
2000	ms
0	ms
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A linear correlation was assumed and myocardial 𝑇"	values were corrected using the 
equation:  𝑇1𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 = 𝑇1𝑢𝑛𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 + 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡 ∗ (𝑋𝑚𝑒𝑎𝑛 − 𝑋𝑝𝑎𝑡𝑖𝑒𝑛𝑡) 
where X is the blood measurement of mean R1, mean R1* or hematocrit, mean is the mean 
for the patient cohort, and the constant was calculated as the slopes from linear regression 
between myocardial 𝑇"	and the blood measurements.  
One observer analyzed the native myocardial 𝑇"	maps acquired in the healthy volunteers. Epi- 
and endocardial borders were cautiously delineated in the 𝑇"	maps. Global 𝑇"	values were 
acquired by eroding 10% from each border to acquire the middle 80% of the myocardium. To 
acquired native 𝑇"	and 𝑇"* blood values, ROIs were placed in both the LV and RV blood 
pools in both of the respective maps.  
5.2.2 Study II 
A clinically available free-breathing flow quantification sequence with retrospective ECG 
gating was used to acquire flow images of the proximal ascending aorta and the proximal 
main pulmonary artery. For further details on imaging parameters see Study II.  
One observer performed flow quantification in the ascending aorta and main pulmonary 
artery using semi-automated methods with manual adjustment in dedicated software by 
Vendor 1 and Vendor 2, respectively. ROIs were drawn in the ascending aorta and main 
pulmonary artery in the magnitude images. These ROIs were automatically outlined in the 
corresponding phase velocity map. Flow measurements were acquired both uncorrected and 
with linear background phase correction in Vendor 1, and both uncorrected and corrected 
with linear and quadratic background phase correction in Vendor 2, respectively. The 
stationary tissue background correction was performed by maximizing the amount of static 
tissue. Static tissue was maximized by including as much visual stationary tissue as possible 
via an increase of the phase deviation threshold. Non-static tissue was excluded by drawing 
an ROI over the lungs, the heart and the major thoracic vessels (Figure 5.3). 
 
Vendor	1	Linear Vendor	2	Linear
Vendor	2	Quadratic
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Figure 5.3. Stationary tissue background correction performed in Vendor 1 and Vendor 
2. This image show two identical transverse slices of the thorax which are used for flow 
quantification in the ascending aorta. The regions of interest (ROIs) in blue shows the 
excluded non-static tissue. The amount of visual static tissue is seen in red using Vendor 1 
(left image). The right image shows Vendor 2. Linear correction is shown in the smaller 
window in the top right corner, and quadratic correction is shown in the smaller window in 
the bottom right corner.  
5.2.3 Study III 
We acquired one short-axis slice during first pass perfusion imaging, both during adenosine 
stress (140 microg/kg/min infusion) and at rest. First pass perfusion was performed with the 
administration of an intravenous contrast agent (0.05 mmol/kg, gadobutrol). The perfusion 
and MBV maps were generated on the scanner using the Gadgetron inline perfusion mapping 
software. Figure 5.4 shows a time line over the CMR exam. 
Furthermore, we acquired a mid-ventricular native myocardial 𝑇"	 map. The map was 
acquired using a MOLLI sequence [59], with a 5s(3s)3s sampling scheme [25]. We also 
acquired a mid-ventricular post-contrast 𝑇"	 map with the same slice position and sampling 
scheme as the native 𝑇"	 map. This map was acquired following intravenous contrast (total 
dose over three boluses: 0.2 mmol/kg gadobutrol), both at rest and during adenosine stress 
(140 microg/kg/min infusion). Using the rest pre- and post-contrast 𝑇"	maps, and stress pre- 
and post-contrast 𝑇"	maps, respectively we generated rest and stress ECV maps offline. See 
Study III for further greater detail of imaging parameters.   
 
Figure 5.4. Timeline over CMR scan. Scouts and cines were acquired first, followed by 
native 𝑇"	 mapping a rest. Following 3 minutes of adenosine infusion, native 𝑇"	mapping was 
acquired, followed by first pass perfusion imaging using gadobutrol (0.05 mmol/kg). After the 
adenosine infusion was terminated a 10-minute pause followed to reach contrast equilibrium. 
First pass perfusion images were acquired using gadobutrol (0.05 mmol/kg) at rest and an 
Scouts
Cines
Native	
T1	rest
Adenosine	stress	infusion	
(140	microg/kg/min)
Native
T1	stress
Gadobutrol
0.05	mmol/kg
First	pass	
perfusion	
stress	
10-minute	pause
First	pass	
perfusion	
rest
10-minute	pause	for	
contrast	equilibrium	
T1	double
dose	rest
T1	double
dose	stress
Start Stop
Adenosine	stress	infusion	
(140	microg/kg/min)
Start Stop
Gadobutrol
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Gadobutrol
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additional dose of gadobutrol (0.1 mmol/kg) was administered. A post-contrast 𝑇"	map was 
acquired at rest, and at stress following 3 minutes of adenosine infusion. 
One observer acquired perfusion, MBV and ECV values by drawing a circumferential ROI in the 
mid-mural myocardium in the respective mid-ventricular short-axis maps, both at rest and stress.  
5.2.4 Study IV 
LGE images, and post-contrast 𝑇" were acquired around 10-15 minutes and 20-25 minutes 
respectively, after intravenous administration of 0.2 mmol/kg body weight of gadoteric acid 
(Gd-DOTA). The post contrast 𝑇"	 maps were acquired using MOLLI with a 4(1)3(1)2 
sampling scheme [118] and motion correction [59]. SynLGE images were generated offline 
from acquired post contrast 𝑇"	maps using dedicated in-house developed software. Please see 
study IV for further detail on imaging parameters. 
LGE and SynLGE images were anonymized and presented to two independent observers in a 
random order. The two observers were blinded to patient identity, clinical data and CMR 
date. The LGE and SynLGE images were evaluated with regards to the presence or absence 
of ischemic or non-ischemic focal fibrosis. Identification of focal fibrosis in either LGE or 
SynLGE images required confirmation in two continuous or orthogonal slices. 
The cases of disagreement between the observers were re-evaluated together in order to reach 
consensus. Blinded comparison of the consensus assessment of SynLGE and LGE images 
was performed for evaluation of the localization and origin of focal myocardial fibrosis on a 
per-patient basis.  
5.3 STATISTICAL ANALYSIS 
Statistical analysis was performed using Microsoft Excel (Microsoft, Redmond, Washington, 
USA) and IBM SPSS Statistics for Macintosh, version 22 and 23 (IBM Corp, Armonk, N.Y, 
USA). Continuous, normally distributed variables as determined by the Kolmogorov-
Smirnov test were reported as mean ± standard deviation. Continuous, non-normally 
distributed variables, were reported as median [interquartile range]. Ordinal variables were 
reported as percentages. Means in normally distributed data were compared by the paired or 
unpaired t-test as appropriate, and standard deviations by the F-test. Medians in non-normally 
distributed data were compared using the Mann-Whitney U-test or Wilcoxon signed rank test 
as appropriate, and variability by non-parametric Levene’s test. Ordinal variables were 
evaluated for differences with McNemar’s test. Relationships between two continuous 
variables were assessed with Pearson’s linear correlation, and presented as R2. Multivariate 
linear regression was performed to obtain slopes for combinations of variables. Statistical 
significance was defined as p<0.05.  
5.3.1 Study II 
Patient characteristics were dichotomized according to high and low values in relation to the 
median, and assessed for changes in precision following background correction. Intra-
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observer variability was calculated as the difference between two measurements divided by 
their mean, both for uncorrected and corrected measurements. Change in flow following 
background correction was calculated as the difference between corrected and uncorrected 
measurement divided by their mean. Bonferroni correction was applied where m=20 and 
alpha=0.05, resulting in p<0.0025 as the level of statistical significance for analyses of 
multiple patient characteristics.  
5.3.2 Study IV 
Chi square (χ,) test was used for comparing nominal variables. Cohen’s kappa (κ) coefficient 
was used to evaluate inter-observer agreement and comparing LGE and SynLGE. The κ 
statistic was interpreted according to the definitions of Landis and Koch where <0.2 indicate 
poor agreement, 0.2-0.4 fair, 0.41-0.6 moderate, 0.61-0.8 substantial, and 0.81-1.0 almost 
perfect agreement. With LGE as the reference standard, sensitivity, specificity, NPV and PPV 
of SynLGE were calculated to detect ischemic and non-ischemic myocardial scar at the 
segmental level.  
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6 RESULTS 
6.1 DIAGNOSTIC PRECISION 
Blood correction for native myocardial 𝑇"	values increased precision with 14% in the 
derivation cohort, which was maintained with a 13% increase in the validation cohort (Figure 
6.1).  
 
Figure 6.1. Standard deviations of uncorrected and corrected myocardial 𝑻𝟏. This bar 
graph shows the standard deviation of native myocardial 𝑇"	(ms) before and after blood 
correction. The derivation cohort is shown with black bars, and the validation cohort is 
shown in white bars. The increase in precision in percent is denoted by the triangles.  
The number of patients with a Qp/Qs outside of the normal range decreased following 
stationary background correction from 16/91 (18%), to 9/91 (10%, p<0.001) with Vendor 1 
and linear correction, to 9/91 (10%, p<0.001) with Vendor 2 and linear correction, and to 
6/91 (7%, p<0.001) with Vendor 2 and quadratic correction (Figure 6.2).  
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Figure 6.2. Change in number of patients with pathological Qp/Qs following stationary 
tissue background correction (n=91). Stationary tissue background correction reduced the 
number of patients with a Qp/Qs outside of the normal range. The triangles denote the 
reduction of patients with Qp/Qs outside of the normal range in percent.   
Stationary tissue correction increased precision in Qp/Qs compared to uncorrected 
measurements with 25-30% (Figure 6.3). 
 
Figure 6.3. The change in precision following linear and quadratic correction with 
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precision in Qp/Qs increased. There was a trend towards increased precision in Qp/Qs using 
linear correction Vendor 2, and quadratic correction increased the precision in Qp/Qs in 
Vendor 2. 
6.2 SEX DIFFERENCES 
Blood correction eliminated sex differences in myocardial 𝑇"	values in the derivation cohort 
(Figure 6.4) and in healthy volunteers (Figure 6.5) and reduced the sex differences in the 
validation cohort (Figure 6.6) 
 
Figure 6.4. Myocardial 𝑇"	values in the derivation cohort separated by sex. This figure 
shows the mean±95% limits of agreement before (black boxes) and after (white boxes) blood 
correction, separated by sex. There was a difference between males and females in the 
average myocardial 𝑇"	values before blood correction, however that difference was 
eliminated following blood correction.  
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Figure 6.5. Myocardial 𝑇"	values in healthy volunteers separated by sex. The figure 
shows the mean±95% limits of agreement for myocardial 𝑇"	values for females (green boxes) 
and males (white boxes), both uncorrected and blood corrected. The average myocardial 𝑇"	values differed between the males and the females before blood correction, but the 
difference was eliminated following blood correction.  
 
1150
1100
1050
1000
950
900
Na
tiv
e	
m
yo
ca
rd
ia
l	T
1	
(m
s)
Males Females Males Females
Uncorrected Corrected
p<0.001
p=0.20
M
ea
n	
m
yo
ca
rd
ia
l	T
1	
±
2	
SD
Validation	cohort,	n=200	
p<0.001
p=0.02
Uncorrected	T1
Corrected	T1	
p<0.001
p<0.001
900
950
1000
1050
1100
1150
Females Males
Sex
  45 
Figure 6.6. Myocardial 𝑇" values in the validation cohort separated by sex. This figure 
shows the mean±95% limits of agreement before (black boxes) and after (white boxes) blood 
correction, separated by sex. There was a difference between males and females in the 
average myocardial 𝑇"	values before blood correction. This difference was reduced, but not 
eliminated after blood correction. 
In females, linear stationary tissue background correction increased the magnitude of Qp/Qs 
whereas quadratic correction did not (Figure 6.7). However, neither linear nor quadratic 
correction affected the precision of Qp/Qs. In contrast, linear stationary tissue background 
correction increased the precision in males using Vendor 1, and did not affect the magnitude 
(Figure 6.8). 
Figure 6.7. Change in mean values for all females following stationary tissue 
background correction (n=35). The magnitude of Qp/Qs was higher following linear 
correction in both Vendor 1 and 2, however the magnitude remained unchanged following 
quadratic correction using Vendor 2.  
Q
p/
Q
s	f
em
al
es
,	n
=3
5
1.2
1.1
1.0
0.9
Vendor	1	
Uncorrected
Vendor	2
Uncorrected
Vendor	2
Linear	Correction
Vendor	2
Quadratic	Correction
p<0.001
p=0.23
p<0.001
Vendor	1
Linear	Correction
 46 
 
Figure 6.8. Change in median values for all males following stationary tissue 
background correction (n=56). Neither liner nor quadratic correction changed the 
magnitude of Qp/Qs in males. 
Healthy female volunteers had higher myocardial perfusion, MBV and myocardial 
extracellular volume compared to males, both at rest and during adenosine stress (Figures 
6.9-11).  
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Figure 6.9. Sex differences in myocardial perfusion at rest and during stress. Females 
(white bars) had higher perfusion compared to males (black bars) both at rest and during 
adenosine stress. Error bars show one standard deviation.  
  
Figure 6.10. Sex differences in myocardial blood volume at rest and during stress. 
Females (white bars) had higher blood volume compared to males (black bars) both at rest 
and during adenosine stress. Error bars show one standard deviation.  
 
 
Figure 6.11. Sex differences in myocardial extracellular volume at rest and during 
stress. Females (white bars) had higher extracellular volume compared to males (black bars) 
both rest and during adenosine stress. Error bars show one standard deviation.  
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6.3 DIAGNOSTIC ACCURACY 
Focal myocardial fibrosis was identified by consensus assessment with LGE in 40% of 
patients. The patterns of focal myocardial fibrosis were non-ischemic origin (n=24), ischemic 
origin (n=18) or both (n=3). SynLGE yielded a modest diagnostic sensitivity (77%), a very 
high specificity (98%), a very high PPV (97%), a high NPV (86%) and an overall accuracy of 
98/109 (90%), compared to LGE as a reference standard, Table 2. The overall blinded 
comparison of SynLGE versus LGE yielded κ=0.78.  
 
Figure 6.12. Comparison of late gadolinium enhancement (LGE) images and synthetic 
LGE images derived from post-contrast 𝑇" mapping. 
(A) cases with concordant assessment of focal myocardial fibrosis, (B) cases where LGE but 
not SynLGE detected focal myocardial fibrosis by blinded assessment and (C) focal 
myocardial fibrosis identified by SynLGE but missed by LGE. 
When analyzing ischemic cases, focal myocardial fibrosis was identified in 17% of patients. 
Compared to LGE, SynLGE yielded a modest sensitivity (83%), a very high specificity 
(100%), a very high PPV (100%), a very high NPV (96%) and an overall accuracy of 79/82 
(96%), Table 2.  
When analyzing non-ischemic cases, focal myocardial fibrosis was identified in 22% of 
patients. Compared to LGE, SynLGE yielded a modest sensitivity (71%), a very high 
specificity (98%), a high PPV (94%), a high NPV (90%) and an overall accuracy of 81/89 
(91%), Table 2.  
  
LGE           SynLGE 
A. 
LGE           SynLGE LGE           SynLGE 
LGE           SynLGE 
B. 
C. 
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Table 2. Cases with focal myocardial fibrosis using LGE and SynLGE 
a) Overall 
SynLGE 
LGE 
Positive 
 
Negative 
 
Total 
Positive 34 1 35 
Negative 10 64 74 
Total 44 65 109 
b) Ischemic 
SynLGE 
LGE 
Positive 
 
Negative 
 
Total 
Positive 15 0 15 
Negative 3 64 67 
Total 18 64 82 
c) Non-ischemic 
SynLGE 
LGE 
Positive  
 
Negative 
 
Total 
Positive 17 1 18 
Negative 7 64 71 
Total 24 65 89 
a) Shows the overall analysis for SynLGE versus LGE as a reference standard (n=109 
patients). Chi square p<0.0001 b) Shows the analysis for ischemic focal fibrosis (n=82 
patients). In this analysis, the patients (n=3) with both ischemic and non-ischemic focal 
fibrosis were excluded. c) Shows the analysis for non-ischemic focal fibrosis (n=89 patients). 
In this analysis, the patients (n=3) with both ischemic and non-ischemic focal fibrosis were 
excluded.  
Abbreviations: LGE = late gadolinium enhancement; SynLGE = synthetic LGE. 
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7 DISCUSSION 
We have identified sex differences in several aspects of clinical CMR imaging that affect 
precision, and have explored post-processing methods for increasing diagnostic precision and 
accuracy in clinical CMR. Furthermore, we have provided mechanistic insights into the 
normal myocardial physiology by exploring different parameters of the myocardial 
circulation during rest and stress in healthy volunteers. It is evident that post-processing is a 
powerful tool to increase diagnostic precision, however in a clinical setting post-processing 
poses a tedious time challenge and it would therefore be beneficial with increased precision 
in the imaging sequences.  
7.1 DIAGNOSTIC PRECISION IN NATIVE 𝑻𝟏	MAPPING 
We have proposed and validated a blood correction method for clinical native 𝑇"	mapping 
using the 5(3)3 MOLLI protocol with the mean (average LV + RV) blood measurements. 
Using the mean blood measurements allows for automated blood correction 𝑇"	maps to be 
produced, by automated blood pool detection. Further studies are needed where native 𝑇" 
maps and blood corrected 𝑇"	maps are compared head to head, in order to see how blood 
corrected 𝑇"	maps perform with native 𝑇"	maps as an independent reference standard. It has 
been suggested that blood correction may increase precision in detection of fibrosis in the LV 
in patients with pulmonary hypertension [119]. It would be interesting to see if this could be 
applicable to diseases that are detected by native 𝑇"	mapping, such as iron-overload 
cardiomyopathy, Anderson-Fabry disease or amyloidosis. The accuracy and precision could 
likely increase in two ways – either by reducing the reference values and thereby values that 
are considered normal today would be considered diseased, or by blood correction pushing 
the 𝑇"	values outside the normal range on a per patient basis.  
Anderson-Fabry disease is characterized by accumulation of glycosphingolipids in the 
cardiomyocytes, which lead to a decrease in native 𝑇"values [120]. Imagine a woman with 
Anderson-Fabry disease and let’s say that her hematocrit is in the lower range. Her blood has 
a lot of plasma with high 𝑇"	and less hemoglobin with low 𝑇", so her mean native blood 𝑇"	is 
1673 ms and her myocardial native 𝑇"	is 903 ms, just above the lower limit of normal of 900 
ms. By applying our validated blood correction model on a per patient basis, her native 𝑇"	value becomes 890 ms – clearly diseased. However, by adjusting the reference values 900 
– 1100 ms with a 13% reduction, assuming that the reduction is equally distributed, the 
reference values would be 913 – 1087 ms, thus making 903 ms diseased too. One might 
speculate that blood corrected native 𝑇" maps can add benefit in difficult cases like this, likely 
as an effect on both the changes in native 𝑇"	in a per patient basis and in the reduction in the 
normal ranges. The accuracy and precision of native 𝑇"	maps are, by definition, going to 
increase as a result of the reduction in normal ranges with blood corrected native 𝑇"	maps. It 
may be that the changes on a per patient basis will add to the accuracy and precision of blood 
corrected 𝑇"	maps, by further separating normal from diseased values as exemplified with the 
woman with Fabry’s disease. With a native myocardial 𝑇"	value of 890 ms and reference 
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values of 913 – 1087 ms, it is obvious that this woman has myocardial engagement of 
Fabry’s disease. However, blood corrected 𝑇"	maps need to be studied compared to native 𝑇"	maps, and compared to outcome during follow up.   
7.1.1 Choice of protocol  
There are several MOLLI protocols in clinical use for native 𝑇"	mapping, and during the 
course of this thesis the clinical protocol at our site has changed from 5(3)3, to 5(3s)3 to 
5s(3s)3s, which is the protocol shown to have the best precision. Furthermore, the 5s(3s)3s 
protocol is highly reproducible, has few image artifacts, and requires only a short breath-hold. 
The ShMOLLI protocol performs very similar to the 5s(3s)3s protocol, however with a 30% 
loss of precision [25]. The best accuracy is achieved with SASHA, however SASHA suffers 
from limited precision [58]. Therefore, Saturation-Pulse Prepared Heart-rate independent 
Inversion-Recovery (SAPPHIRE) was developed [121], which combines the saturation and 
inversion recovery approaches, thus mitigating heart rate dependency and increasing 
precision. In head to head comparisons in phantoms, MOLLI and ShMOLLI had higher 
precision compared to SAPPHIRE and SAHSA, whereas SAPPHIRE and SASHA had 
higher accuracy compared to MOLLI and ShMOLLI [122]. It is worth noting that the 
accuracy differed by 63 ms with ShMOLLI, and 44 ms with MOLLI, and that there was a 
trend towards higher precision with MOLLI compared to ShMOLLI, (4.0 ms compared to 5.6 
ms, p=0.07).  The higher accuracy in SAPPHIRE and SASHA is due to saturation recovery 
imaging circumventing several of the issues with inversion recovery such as T2 dependence, 
magnetization transfer effects, and the dependence of inversion efficiency [25, 58, 122]. 
Extensive work on increasing the precision of saturation recovery techniques include free-
breathing SASHA with a precision similar to breath-held 5(4)3 MOLLI over 30 s sampling 
[123] [sic], and SASHA with less than 30% precision-loss compared to 5(3)3 MOLLI at 3T 
[124].  
7.1.2 The future of 𝑻𝟏	mapping 
In the clinic, today one has to choose between precision and accuracy with regards to the 
choice of IR techniques (MOLLI and ShMOLLI) versus SR techniques (SASHA and 
SAPPHIRE) for native T1 mapping. MOLLI has better precision, but worse accuracy 
compared to SR techniques. From a clinical perspective, one might argue that in the clinical 
context of native 𝑇"	mapping, precision is more important than accuracy. Quantification 
allows for an objective measure to detect or follow as physiological phenomenon over time, 
following that the measurements have high precision. Of course, the best-case scenario would 
be a measurement that is both accurate and precise. However, if forced to choose today 
between MOLLI and precision or SAHSA and accuracy, the argument for choosing MOLLI 
over SR techniques would be based on precision. In order to identify subtle changes, low 
variability is paramount, even if the actual measure may systematically differ from the true 
value. This is evident with MOLLI in the clinical situation today. The technique is widely 
available, and is a highly sensitive measure of tissue characterization, which has 
demonstrated an ability to differentiate disease from healthy myocardium, despite 
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inaccuracies. There is clinical knowledge on what a native 𝑇"	value signifies using a MOLLI 
sequence, and how it can be used to guide patient management. SR techniques still have the 
advantage that, with more research, the precision may increase, thus becoming both accurate 
and precise for measuring 𝑇".	In that case, one could argue that SR techniques have to show 
an incremental benefit compared to MOLLI to gain acceptance in the field. 
Another benefit of SR techniques is that the ECV-measurements seem to be more accurate, 
compared to MOLLI measurements. Furthermore, SR techniques also seem to have higher 
accuracy across the LV – same mean value across all three slices compared to MOLLI [124]. 
ECV has clinical prognostic importance [125], and this could further add to the clinical 
applicability of SR techniques, despite that they are currently not as commonly used as 
MOLLI. However, it would be of great importance that SR techniques becomes precise and 
reproducible, so that the CMR field can reach a consensus on which technique to use in order 
to allow for multicenter studies, and for 𝑇"	mapping to become a well-established tool for 
clinical decision-making. 
7.2 DIAGNOSTIC PRECISION IN FLOW QUANTIFICATION 
We have shown that post-processing by stationary tissue background correction reduces 
measurement variability in Qp/Qs, and furthermore reduces the number of patients with a 
Qp/Qs outside of the normal range. The stationary tissue background correction of phase 
contrast velocity encoded images are integrated in the clinical software products, are used 
clinically every day and the correction takes little additional time to perform. The differences 
in precision are relatively small in absolute numbers, but as much as 25-30 % in relative 
terms. Furthermore, the number of patients with a Qp/Qs outside of the normal range is 
decreased with over 50% following stationary background correction. This is in stark contrast 
to previous findings in patients with congenital heart disease without known cardiac shunts, 
where the number of shunts increased following correction [126]. However, that study was 
small (n=24), and patients with congenital heart disease may have more valvular disease, 
which may have impacted the results as the effect of valvular disease on stationary tissue 
background correction has not yet been fully evaluated. The main limitation in our study is 
the lack of an independent reference method to determine that the patients indeed had no 
shunt. Future studies could be performed in a clinical population that have been deemed to 
have no shunt by transesophageal echocardiography. Furthermore, the normal variability of 
Qp/Qs in unknown, therefore it was not possible to do an a prior power and sample size 
calculation. Moving forward, the results in this study can be used as a basis for either 
estimation of a plausible change in Qp/Qs values, or calculating a sample size needed for a 
specific outcome. Furthermore, it would be interesting to see what actually happens in a 
patient cohort with known cardiac shunts – does the Qp/Qs increase or decrease following 
stationary tissue background correction? Looking at the results from our cohort without 
cardiac shunts, stationary tissue background reclassified patients from shunt to no shunt in 
10-12 cases. One might hypothesize that Qp/Qs increases following stationary tissue 
background correction and that, in a few cases, patients would be reclassified from having no 
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shunt to having a shunt. In summary, our data supports that it is of clinical importance to 
perform stationary tissue background correction in the clinical setting to reduce variability 
and increase diagnostic precision.  
7.3 ISCHEMIC HEART DISEASE AND CMR 
CMR allows for a comprehensive, multi-parametric cardiac assessment, and is rapidly 
moving towards a becoming a one-stop-shop technique. CMR has superior diagnostic 
properties in ischemic heart disease, with important prognostic implications [127]. Seven to 
fifteen percent of ACS patients have non-obstructive coronary arteries [128], and this is more 
common in women than in men [129]. CMR can identify different underlying etiologies in 
these patients [130, 131]. Overall, CMR can provide a final diagnosis in the majority of 
patients, and has a significant clinical impact in two thirds of patients by either providing a 
new diagnosis or changing clinical management [132]. Furthermore, CMR can guide 
revascularization in coronary chronic total occlusion to reduce ischemic burden [133]. Since 
2013 CMR has a class 1B indication for risk stratifications in patients with stable, obstructive 
CAD to guide clinical decision making, and assess patients with intermediate PTP of CAD 
[106]. Stress CMR also has a class 1A indication for assessing residual ischemia and viability 
in STEMI patients [97], and has been given a class 1A indication for assessing suspected 
CAD in patients with intermediate PTP for myocardial revascularization [134]. However, as 
suggested by Study III, there is a current knowledge gap on sex differences in CMR and how 
these affect diagnostic precision.  
7.3.1 Differences between the sexes in ischemic heart disease 
Older women have a worse outcome in ACS compared to men, often attributed to that they 
are older, have more co-morbidities and therefore receive less aggressive treatment. It would 
therefore be logical to assume that younger women, that do not have more co-morbidities, 
receive the correct treatment and therefore having a reduced the mortality rate. On the 
contrary, middle-aged and younger women have a higher risk of adverse events following an 
AMI. Women that are younger than 55 years old have a three-fold higher mortality rate in 
hospital and an increased risk with 50% of death over 2 years compared to young men [135-
137]. Some data suggest that younger women are sicker on admission and receive less 
aggressive and effective treatment and care [138-141]. Other explanatory factors are that 
women present with different symptoms [142] and that young women more often suffer from 
depression [143]. These factors are more gender-related and this is why it is of such 
importance to investigate physiological, sex-related factors.  
It is evident in Study III that women have higher myocardial perfusion and blood volume 
compared to men. The healthy volunteers in the study were predominately young, thus 
providing a potential sex-related factor for the differences in outcomes in younger women. 
With a higher myocardial perfusion and MBV it is possible that the female myocardium is 
more susceptible to ischemia, causing more damage in the myocardium in females compared 
to males when exposed to ischemia. Estrogen has been shown to have a vasodilatory effect 
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[144], and it has been suggested that the loss of estrogen in peri- and postmenopausal women 
may cause vasoconstriction leading to ischemia with normal coronary arteries [101]. In Study 
III we also learned that young women have higher ECV compared to men. MBV and ECV 
are related, and we postulate that the increase in MBV contributes to the increased ECV in 
women compared to men. This is due to the fact that the technical methodology for ECV 
mapping utilizes the plasma volume (the extracellular space of the intravascular 
compartment) to calculate the ECV in myocardium. However, it is also possible that the 
increased ECV contributes to the increased MBV in women compared to men. Furthermore, 
all variables that differed between the sexes in Study III were investigated for with regards to 
linear correlation with MBV, myocardial perfusion and ECV, respectively. No parameter 
correlated with MBV, myocardial perfusion or ECV at both rest and stress, respectively. This 
suggests that sex is an important, independent factor that is not explained by factors such as 
body surface area.  
7.3.2 Physiological measurements of myocardial ischemia 
In the healthy heart, myocardial perfusion is tightly regulated by dynamic changes in both the 
epicardial and intramyocardial coronary vasculature, as well as the downstream 
microcirculation. Roughly 75% of the oxygen is extracted from the coronary circulation by 
the myocardium during rest. This leaves a minimal oxygen reserve, and therefore, any 
increase in oxygen consumption requires an increase in myocardial perfusion. The regulation 
of myocardial perfusion is mainly controlled by the microcirculation, as the epicardial 
coronaries only contribute with roughly 10% of the coronary resistance. The capillary system 
and venules serve as capacitance vessels, holding 90% of the intramyocardial blood volume, 
but offer only minimal resistance. The coronary resistance is primarily controlled by 
prearterioles and arterioles during normal conditions. As a result of autoregulation, 
myocardial perfusion remains relatively constant over a wide range of perfusion pressures, 
through shear stress and pressure-dependent myogenic mechanisms. Coronary flow decreases 
exponentially below the lower pressure limit of autoregulation, which results in myocardial 
ischemia. The complexity of the dynamic control of myocardial perfusion further underscores 
the complex and difficult task to truly identify myocardial ischemia, both invasively and non-
invasively. 
7.3.2.1 CFR, RFR, FFR and hyperemic myocardial perfusion 
CFR is determined by the maximal hyperemic perfusion divided by the baseline perfusion. 
CFR will be affected both by epicardial stenosis, and microvascular disease, and normal 
ranges depend of method of quantification, however CFR <2.0 is generally considered to be 
consistent with ischemia [145]. A closely related parameter is relative CFR (RFR), which can 
be used to assess an epicardial stenosis. RFR is defined by dividing the maximum stress 
perfusion in a diseased coronary segment by the maximum stress perfusion in a segment 
without disease [146, 147]. In the situation where microvascular disease is not present, the 
RFR for a stenosis should be identical to the pressure-derived fractional flow reserve (FFR), 
however RFR as a measurement does not capture microvascular dysfunction like CFR [146]. 
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Hyperemic myocardial perfusion (ml/min/g), sometimes referred to as hyperemic MBF, has 
also been suggested as a measurement for detecting ischemia by using a threshold during 
hyperemia [148]. All of these non-invasive measurements can now be measured with 
quantitative CMR perfusion mapping. However, as shown in Study III, sex differences might 
have to be accounted for, especially in young people. This is particularly important when 
using myocardial perfusion as a parameter, as sex-dependent cut off values for ischemia 
might be necessary. Currently, we are lacking knowledge on sex differences in myocardial 
perfusion using CMR in other age groups, as Study III was conducted in primarily in young 
volunteers. Drawing upon the results from heart rate variability studies on sex differences 
[85], it is possible that sex differences decrease after 50 years of age (likely due to 
menopause). In a cohort without obstructive CAD, there was a clear sex difference in 
myocardial perfusion using PET, both at rest and during stress, which was still evident 
following correction for rate pressure product (RPP), which is a marker of cardiac work 
[149]. However, there was no sex difference in CFR, which is logical since myocardial 
perfusion is higher during both rest and stress, and this effect is accounted for by the ratio 
between them. This supports that, when using myocardial perfusion for ischemia detection, it 
is likely important to take sex differences into account.  
FFR is an invasive measurement where the change in pressure over a stenosis is measured, 
during maximal hyperemia. FFR is based on the notion that pressure varies linearly with 
flow, so a drop in pressure reflects a drop in flow over a stenosis, and thereby identifies 
ischemia. FFR has emerged as the reference standard to evaluate stenosis severity and guide 
treatment [150-152]. There are several different methodological issues with all of these 
parameters, and furthermore, there are complex relationships between diffuse microvascular 
dysfunction and focal obstructive CAD.   
7.3.2.2 Ischemia as a physiological continuum of focal and diffuse disease 
All of the above-mentioned measurements aim to, in a binary fashion, separate healthy from 
disease, or significant from non-significant myocardial ischemia. This reflects the clinical 
ideal: a clinician desires a simple cut-off to perform an intervention with known effects on 
hard endpoints like mortality. However, excepting that one single measurement can 
dichotomize the complex reality of myocardial ischemia in all patients with different 
diseases, backgrounds, ethnicity and sex is likely an oversimplification [153], and likely 
underestimates the complexity of the myocardial microcirculation. Van Horssen et al., has 
shown that epicardial penetrating arteries define separate perfusion territories, that likely 
relate to borders of ischemic and infarcted tissue in dogs [154]. The perfusion territories 
increase in size, but decrease in number when moving from the epicardium towards the 
endocardium, highlighting that the endocardium is only perfused by a small subset of 
penetrating arteries. As the evolution of infarcts in dogs is most similar to humans compared 
to other species [155], it is possible that the microcirculation is similar in humans. This could 
add to the knowledge of the pathophysiology of INOCA: if microvascular disease, or only 
mild stenosis, develops in the few penetrating arteries, the endocardium may be highly 
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susceptible to the emerging ischemia, compared to the epicardium that has more vessels with 
smaller perfusion territories. It would be interesting to see if there are sex differences in the 
coronary microvasculature. Larger and fewer perfusion territories could be an explanatory 
variable for the sex differences in MBV.  
There are different causes myocardial ischemia: the focal epicardial coronary stenosis, the 
diffuse INOCA due to microvascular disease and the combinations of the focal and diffuse 
disease of different severity. It is clear that CFR, RFR, FFR and myocardial perfusion all can 
identify severe stenosis in need of revascularization [146, 153, 156]. However, it is likely 
only CFR that can identity diffuse microvascular disease, INCOA, and also has the advantage 
of identifying both flow-limiting stenosis and microvascular disease [157].  In case CFR is 
used, the data suggests that there is no need for sex specific cut-off values. Focal stenosis is 
associated with diffuse disease [158], which has the implication that the risk with the focal 
disease needs to be higher than the risk with the diffuse disease in order for intervention to be 
successful. Furthermore, an FFR can be low in a visually small stenosis [159], but with a 
normal CFR, and it is unclear if these patients will benefit from revascularization. An FFR 
can also be high, but with a low CFR, thus reflecting diffuse microvascular disease. FFR after 
intervention inversely correlates with risk, which is likely a reflection of residual diffuse 
microvascular disease [158]. FFR thereby fails to identify these patients, however they can 
likely be identified by CFR or myocardial perfusion. However, MBV has also become an 
interesting parameter to assess myocardial ischemia. In case of a significant stenosis, the 
vasculature would be fully dilated at rest and during stress there is no reserve left to dilate. 
This means that the MBV is high a rest, with little to no response during stress in obstructive 
CAD. Further studies on MBV maps in patients may elucidate this further, and highlight if 
sex difference exist in patients with obstructive CAD.  
Significant stenosis can be detected with the response native 𝑇" values during stress [160]. 
Furthermore, the response in native 𝑇"values shows promise in differentiating between 
obstructive CAD and microvascular disease [161].  As the cut-off value was a ratio of native 𝑇"native values between rest and stress, sex differences in native 𝑇" is likely mitigated. 
However, this needs to be investigated to ensure that sex differences in the ratio of native 𝑇"	values at rest and stress does not affect the diagnostic ability.  
7.3.2.3 Integrating all physiological parameters 
There has been a remarkable evolution in cardiology for guiding the treatment of stable 
obstructive coronary artery disease, moving from anatomical to physiological measurements 
propelled by paradigm-shifting introduction of FFR [152]. However, it is evident that the 
binary decision of intervention is not sufficiently answered by one dichotomous parameter. 
As suggested by Gould and Johnson [153], the field needs to continue the journey towards 
handling the coronary circulation as a complex and multidimensional system, that requires an 
integration of several variables to make the decision to do an intervention or not to an 
intervention. With the findings of sex differences of several different parameters pertaining to 
the coronary circulation, one might argue that it is not just the different measurements of the 
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coronary circulation that need to be taken into account, but also sex. It is evident in normal 
myocardial physiology that sex is a relevant parameter and should be considered, as women 
have higher myocardial perfusion, MBV and ECV compared to men. The medical field is 
moving towards personalized medicine – and therefore one might argue that the imaging field 
needs to consider personalized diagnostics, the choice of imaging method should also be 
based on several parameters such as age, sex, ethnicity in order to increase diagnostic 
precision and accuracy.  
7.3.3 CMR compared to other imaging modalities 
Previously, myocardial ischemia has been detected by CMR using qualitative assessments, or 
semi-quantitative assessments based on the time-intensity curves following first pass 
perfusion with a gadolinium-based contrast agent. With the recent development of 
quantitative perfusion mapping [45] evaluated in this thesis, CMR now has the same ability 
as PET to quantify of both CFR and visualization of single vessel stenosis [162]. Myocardial 
contrast echocardiography (MCE) has been validated for absolute quantification of MBV and 
myocardial perfusion [163, 164]. MCE utilizes a continuous infusion of microbubbles as a 
contrast agent which are destroyed by a high-intensity acoustic signal, and the inflow of 
microbubbles thereafter generates time-acoustic intensity curves. The main disadvantages of 
MCE are operator dependency and limited spatial resolution due to the acoustic window. 
SPECT utilizes the relative intensity of radiotracers to identify areas with reduced myocardial 
perfusion, and thereby inherent lacks the ability of absolute quantification of myocardial 
perfusion, and detection of INOCA.  
A reason for the limited sensitivity and specificity of some imaging modalities, particularly in 
women, may be the overrepresentation of INOCA in women. Historically, imaging 
modalities haven been validated for identifying stable obstructive CAD against anatomical 
assessment with angiography. With the emerging knowledge on physiological measurements 
for intervention in obstructive CAD, and the knowledge on INOCA there is a need to 
reevaluate the different imaging modalities with regards to their potential to identify stable 
coronary syndromes; obstructive CAD and INOCA, and further characterize the INOCA 
subgroup with myocardial ischemia.  
7.3.4 Imaging of focal fibrosis with CMR 
The presence of ischemic heart disease can be detected by LGE, and LGE is the references 
standard for viability assessment [10]. We showed that SynLGE had limited sensitivity to 
detect focal myocardial fibrosis, commonly referred to as scar, of any origin compared to 
LGE. However, SynLGE has been shown to have an excellent agreement with LGE in 
ischemic heart disease [165, 166]. In our study, we looked at both ischemic and non-ischemic 
focal fibrosis, which may account for some of the differences in result. Furthermore, only 
SynLGE and LGE images were assessed in this study. In order to evaluate how SynLGE 
performs clinically, a study could be designed in a way where the observers perform a full 
clinical evaluation, with both native T1 maps, cine images and ECV maps. However, one of 
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the observers may only use SynLGE images, and the another only LGE images. The endpoint 
would be presence of focal fibrosis of any origin on a per patient basis, with LGE as the 
reference standard. This would reflect the clinical decision-making, where images of focal 
fibrosis constitute one piece of the puzzle.  
Clinically one may come across the issue of scarring or focal myocardial fibrosis that heals, 
and becomes no scarring, especially in non-ischemic etiology. There has been a shift towards 
calling the non-ischemic LGE for inflammation instead of scarring, however LGE can be 
present without increased native 𝑇". Drawing upon rubor, tumor, calor and dolor, the classic 
signs of inflammation that Roman scholar Celsus defined in the first century A.D., one would 
expect native 𝑇"	 to be increased and reflect edema in case we have inflammation. The most 
common is of course that LGE and increased native 𝑇"	are present simultaneously, and as the 
edema decreased, LGE either heals or leaves a permanent scar. This would be very 
interesting to investigate further, what is actually causing the focal LGE in the non-ischemic 
etiologies that with times heals without leaving a scar.   
7.4 THE FUTURE FOR QUANTITATIVE CMR 
CMR is an important tool in clinical cardiology where the relatively high spatial resolution 
allows for the assessment of both LV function and mass, the tissue characterization allows for 
the evaluation of the presence and origin of focal fibrosis, edema, and i.e. iron, and with the 
quantitative perfusion mapping both obstructive CAD and INOCA can be quantified. CMR 
has evolved to a one-stop-shop, an imaging tool where almost any cardiac question can be 
answered. The CMR field has to reach a consensus on which method to use for 𝑇" mapping, 
work on even more rapid imaging for i.e. valvular imaging to contribute to flow 
quantification and gain clinical knowledge in quantitative perfusion mapping to even further 
distinguish CMR from other imaging methods. CMR will always have the advantage of being 
free from ionizing radiation, and inherent high signal contrast. Furthermore, new applications 
of non-contrast quantitative imaging make CMR even more available across all patient 
groups. In the meantime, post-processing can be used clinically to increase both precision and 
accuracy of CMR.  
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8 CONCLUSIONS 
There are sex differences in several aspects of clinical, quantitative CMR imaging that affect 
diagnostic precision, and post-processing is a powerful tool to improve both precision and 
accuracy. Study-specific conclusions are: 
• Blood correction increases precision in native myocardial 𝑇"	values with 13% and 
eliminates sex differences in native myocardial 𝑇"	values. Image-based correction of 
native myocardial 𝑇" is valid for clinical use. Blood correction may improve disease 
detection in the clinical evaluation of native myocardial 𝑇", as well as reduce the 
sample size needed for clinical research (Study I).  
• Stationary tissue background correction increases precision in Qp/Qs in a clinical 
population, reduces the number of patients with a Qp/Qs outside the normal range 
and affects sex differences in Qp/Qs (Study II). 
• MBV, myocardial perfusion and myocardial ECV are all higher in female healthy 
volunteers compared to males, and provide mechanistic insight into normal 
myocardial physiology (Study III). 
• SynLGE can provide complementary confidence in the assessment of myocardial 
scarring in complement to convential LGE, and thereby increase diagnsotic accuracy 
and precision (Study IV).  
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